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Abstract 





 Lactobacillus iners, is a gram positive organism recently identified through the use of culture 
independent techniques.  Identified as a major constituent of the vaginal microbiota, epidemiological 
studies have suggested that this organism may not provide the protective effects ascribed to other 
vaginal lactobacilli.  Our work here has identified and characterized a pore forming toxin, Inerolysin, 
produced by this organism.  This pore forming toxin was present in all strains of L. iners tested and 
possessed characteristics which firmly categorize it as a member of the Cholesterol Dependent Cytolsin 
superfamily.    
Additionally, we identified pH as a regulatory factor for the activity of Inerolysin as well as other CDCs.  
Inerolysin was shown to had optimal activity at acidic pH, while other toxins such as pneumolysin and 
arcanolysin had optimal activity at basic pH.  We demonstrate that pH induced changes in activity were 
reversible, suggesting that a reversible conformational change takes place in the protein.  Furthermore, 
our results show that it is the last step in pore formation, the transition from pre-pore to pore, which is 
impaired.  Our attempts to localize this to particular residues were unsuccessful. 
Finally, we sought to understand what the vaginal environment of a Lactobacillus dominated flora would 
look like.  We demonstrate that L. iners induced unique signaling in the vaginal epithelium, leading to 
the production of a unique profile of proinflammatory cytokines as well as antimicrobial peptides.  We 
further demonstrate that some of these responses are mediated by the activity of the pore forming 
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Chapter 1: Introduction 
1.1 Normal Microbiota of the Vaginal Tract 
The microbial inhabitants of the female genital tract and the contribution of these organisms to 
health and disease have been investigated for well over a century, yet they remain 
incompletely understood.  The first studies which yielded information about the complexity of 
this anatomical niche were focused on determining whether puerperal sepsis (also known as 
childbed fever, a bacterial infection acquired during childbirth) resulted from the contamination 
of normally sterile sites or whether the necessary agents already existed in the vagina.  In 1887, 
Döderlein attempted to address this issue by examining the vaginal secretions and uterine 
cavity samples of pregnant women[1, 2].  He found that uterine samples were sterile, but 
vaginal secretions frequently contained pyogenic cocci.  This work was important in 
demonstrating the presence of bacterial species in the vaginal tract, and more importantly 
introduced us to the first descriptions and images of lactobacilli, which was referred to as the 
Döderlein bacillus (and would later be identified as Lactobacillus acidophilus)[3].   
These early studies were dependent upon the growth of these bacteria in rich media and 
identification and characterization based on observable characteristics (shape, Gram stain, and 
arrangement of cells).  With advances in the bacteriological culture strategies, scientific 
understanding of the vaginal microbiota became significantly more nuanced.  While yielding 
important information about the composition of the colonizing microbiota, this approach was 
inherently biasing the picture obtained, as only a small fraction of the colonizing microbiota 
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could be cultured in the laboratory, either because they could not grow on traditional media or 
because they were present in such low abundance.   
In the 1980’s, several groups demonstrated that the phylogenetic relationships of several 
bacteria could be determined by the comparison of a stable part of the genetic code.   The 16S 
rRNA gene was chosen because of its length (large enough to be sequenced directly) and 
because the amount of sequence change is a product of the rate of change and the time (so 
greater sequence change correlates to the phylogenetic distance of two sequences since they 
diverged from their last common ancestor)[4].   Contained within the 16SrRNA gene are “hot 
spots” that show larger number of mutations.  As our understanding grew, it became clear that 
these short regions could also yield significant phylogenetic information and allow for a higher 
resolution between species (as these regions contained more changes between species).  
Briefly, primers are generated to the conserved regions of the 16S rRNA gene, producing a 
polymerase chain reaction (PCR) product that spans one or more of these hypervariable 
regions. These products can then be analyzed in several ways to assess community structure. 
These methods include terminal restriction fragment length polymorphism (T-RFLP) analysis, in 
which PCR products are generated and digested with restriction enzymes, yielding patterns of 
fragments used for identification. The PCR products may also be analyzed by denaturing 
gradient gel electrophoresis (DGGE) in which they are separated based on sequence differences 
by subjecting them to the activity of a gradient of denaturing chemicals. Whereas T-RFLP and 
DGGE are useful and economical techniques, direct sequencing of 16S PCR products yields the 
most detailed information and, as sequencing costs have decreased, has become the most 
commonly used technique. The recent transition from low-throughput clone library sequencing 
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studies to deep sequencing of PCR amplicons has led to a rapid accumulation of data regarding 
human-associated microbial communities and has been crucial in furthering our understanding 
of the composition and dynamics of the microbiota of the genital tract and their role in health 
and disease[5-8]. 
As deep sequencing has become more cost effective and commonplace, we have gained further 
insight into the diversity that is present between individuals.  One study demonstrated that 
rather than having a core set of microbial species present in the vaginal tract common to all 
women, there were actually five “community state types”, characterized by the dominant 
species present[9]. This work found that community state types I, II, III, and V were dominated 
by a single vaginal Lactobacillus species (either L. crispatus, L. gasseri, L. iners, and L. jensenii 
respectively) while community state type IV was characterized by a high diversity and no single 
dominant Lactobacillus species.  This work and others utilizing culture-independent techniques 
have greatly expanded the census of vaginal microbes.  Among the aerobes and facultative 
organisms, lactobacilli, other Gram-positive rods, staphylococci and streptococci (of both 
pathogenic and non-pathogenic varieties), and Gram-negative enteric organisms can all be 
found at high prevalence in vaginal samples. Likewise, a variety of cultivable anaerobes 
including Prevotella spp., Fusobacteria spp., and others are present in substantial numbers at 
the vaginal mucosal surface[10].  The identification of the high level of diversity in the vaginal 
tract is a first step, and further work is required to understand how these species contribute to 




1.1.1 Role of “Protective” Lactobacilli in the Vaginal Tract 
Döderlein’s work not only established the dominance of vaginal lactobacilli in the vaginal tract, 
but established an important concept with regards to their role in the vaginal tract.  In his study 
of puperal sepsis he suggested that in normal secretions, vaginal lactobacilli were crucial to 
keeping the vagina free of pathogenic bacteria[2].  This crucial concept continued to inform 
studies into the 20th century, and it was later demonstrated that the growth of Lactobacillus 
acidophilus antagonized the growth of Neisseria gonorrhoeae[12].  It has been suggested that 
the protective effects of vaginal lactobacilli can be attributed to several mechanisms, including 
the production of hydrogen peroxide[13] and lactic acid (that maintains the vaginal tract at an 
acidic pH), the production of bacteriocins (small peptides with microbicidal activity) and 
competition for nutrients or receptors at the epithelial cell surface, a phenomenon known as 
bacterial interference.  There has been significant work in understanding the protective effects 
of these organisms and their specific identity in the hopes of developing various probiotics for 
the treatment and prevention of urogenital infections.   
1.2 Bacterial Vaginosis 
Bacterial vaginosis (BV) is a condition characterized by replacement of the normally protective 
Lactobacillus spp. and a massive overgrowth of anaerobic and facultative organisms including 
Gardnerella vaginalis, Atopobium vaginae, Bacteroides spp., Mobiluncus spp., and genital 
mycoplasmas[14, 15].  With the loss of the Lactobacillus species, we also see an elevation of the 
vaginal pH due to their lactic acid producing capability[16, 17].  This alteration in vaginal 
microbiology may lead to symptomatic vaginitis. However, the vast majority of affected women 
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remain asymptomatic[18].   Regardless of clinical presentation, BV is associated with significant 
adverse consequences including miscarriage, preterm birth, chorioamnionitis[19], postpartum 
endometritis and an increased risk of HIV/STD acquisition[12, 20, 21]. This complex disorder is 
exceedingly common, with prevalence rates ranging from 10% to 40%(reviewed in [22]).  
Suboptimal methods of diagnosis reflect the inherent difficulties in precisely defining this 
condition and make the true prevalence difficult to ascertain. 
 
1.2.1 Etiology of Disease 
Despite an understanding of the changes that occur during an episode of BV, the etiology of this 
disease remains unclear and the cause of disease has yet to be identified.  Studies of this 
disease state have yielded several potential candidates as contributing to disease.  In 1955, 
Gardner and Dukes isolated Haemophilus vaginalis, now known as G. vaginalis, from women 
with ‘nonspecific vaginitis’ and postulated that this was the primary etiological agent[23]. Their 
attempts to induce infection in healthy volunteers by inoculating pure cultures of G. vaginalis 
were largely unsuccessful (only one of 13 volunteers infected)[24].  They were, however, able 
to induce vaginitis in 11 of 15 volunteers by inoculating vaginal secretions from affected 
women, suggesting that G. vaginalis alone was not sufficient to induce disease and that 
additional factors/organisms were necessary. Since that time, numerous BV-associated bacteria 
have been identified using both standard culture and cultivation- independent techniques and 
BV is generally regarded as a polymicrobial disease. Nevertheless, G. vaginalis remains one of 
the most frequently isolated organisms in women with BV[25] and its cytotoxicity and ability to 
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produce an adherent biofilm suggests a greater virulence potential relative to other BV-
associated organisms[26-28]. 
Culture based studies have implicated a number of different organisms in the etiology of this 
disease.  Several studies have demonstrated an association between Mobiluncus curtisii[21] 
and BV, with prevalence rates approaching 77%  in BV patients as compared to healthy controls 
where Mobiluncus species were identified in about 6% of samples.  Several studies have also 
identified Mycoplasma hominis as a highly associated BV organism, being present in 24-75% of 
women with BV and only 13-22% of women without BV[29-32]  
The use of cultivation-independent techniques has further enhanced our understanding of the 
microbiology of BV.  Fredricks et al.[33] used 16S rDNA PCR to characterize and compare the 
bacterial communities found in women with and without BV.  They demonstrated that those 
subjects with BV exhibited considerably greater bacterial diversity, with 35 bacterial phylotypes 
detected, 16 of which were newly recognized.  Collectively, these organisms, belonging to the 
Clostridiales group, were referred to as BVAB1, BVAB2, and BVAB3[34].  While there is no 
evidence that these organisms are the causative agents of BV (possibly because of their 
fastidious nature making them difficult to study in a laboratory setting), they are highly specific 
markers of BV[35].  By contrast, women without BV were noted to have relatively 
homogeneous vaginal microbiota, predominantly comprised of lactobacilli.  Despite the 
identification of several BV-associated organisms, a clear link between these species and the 
onset of a BV episode has not been explicitly demonstrated.  Furthermore, these species are 
also notably present in healthy patients, calling into question whether they are each 
7 
 
individually the cause of this disease.  To date, no single organism has been implicated in the 
development of this disease and the sequence of events in the progression of BV remains 




Figure 1.1 Two competing models for the etiology of bacterial vaginosis 
1.2.2 Diagnosis and Clinical Outcome 
Historically, BV was a diagnosis of exclusion.  Women who presented with a discharge but 
lacked detectable yeast cells or Trichomonas infection were given the diagnosis of bacterial 
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vaginosis (then referred to as nonspecific vaginitis).  The use of clinical symptoms for diagnosis 
became more standardized by Amsel[18] who defined BV as having three of the four following 
clinical signs: (i) vaginal fluid with a pH of >4.5, (ii)A homogenous grey discharge,(iii) fishy odor 
after the addition of 10% KOH, and (iv) presence of clue cells on wet mount (shed epithelial 
cells coated with bacterial cells).  Since then, these criteria are still in wide use because of the 
ease with which they can be performed in a clinical setting.  However, a number of studies 
since then have suggested that the use of these subjective criteria can result in misdiagnosis, 
either seeing BV where it is not, or missing it altogether in other patients.  This is particularly 
concerning for women who have an altered vaginal microbiota but lack observable symptoms, 
and thus are currently not treated.  These women, despite having no frank discharge or other 
symptoms, could still suffer from some of the negative consequences associated with BV, 
although the connection between asymptomatic BV and BV associated consequences has not 
yet been examined.     
 
Alternatively, BV may be diagnosed using the Nugent scoring system for interpretation of 
Gram-stained vaginal smears[37]. This method assesses the number of lactobacilli relative to 
BV-associated bacterial morphotypes in order to characterize vaginal microbiota as normal, 
intermediate or abnormal (BV).  A major criticism of this diagnostic strategy is that although 
women with high numbers of Lactobacillus spp. generally do not have BV, it may be incorrect to 
conclude that women with few or no Lactobacillus spp. have BV.  In the study by Ravel et al., 
nearly 25% of asymptomatic reproductive-age women had vaginal bacterial communities in the 
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‘diversity group’ (i.e. not dominated by Lactobacillus spp.)[9].  Additionally, the data we present 
here demonstrates that the presence of lactobacilli in a vaginal smear is not synonymous with 
health, depending on the Lactobacillus species present.   
 
In recent years, there has been an increasing appreciation for bacterial vaginosis as an 
important clinical entity, because of the significant adverse sequelae associated with it.  These 
include an increased risk for pelvic inflammatory disease, increased risk for postpartum 
endometritis, an increased risk for the acquisition of HIV and other STDs, as well as an increased 
risk for low birth weight[38] and preterm birth[39-43]  
Preterm birth is defined as delivery of an infant before 37 weeks.  In the US, it occurs in 11% of 
all pregnancies, and is associated with high costs (in excess of $4 billion/year) and a high rate of 
neonatal morbidity and mortality[44].  Various studies have demonstrated the association 
between BV and the incidence of preterm birth although the exact assessment of the increase 
in risk varies from 1.5-3 fold[42, 45].  The exact mechanism linking BV and preterm birth is 
currently unclear.  However, it has been suggested that BV associated organisms can ascend to 
the upper genital tract and initiate preterm labor via inflammatory processes at this site[40].  
Studies of term labors have yielded a wealth of information about the processes which occur to 
induce the appropriate sequence of events, and these processes may be activated in an 
untimely manner in the setting of vaginal infection.  Specifically, it is thought that bacterial 
PAMPs (Pathogen Associated Molecular Patterns) can activate proinflammatory signaling 
resulting in the production of IL-1β, TNF-α, IL-6, IL-8 and others.  These cytokines can augment 
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their own production as well as result in the production of prostaglandins, matrix 
metalloproteinases, and recruitment of neutrophils and macrophages to the maternal fetal 
membranes, cervix, and myometrium[46].  Additionally, several studies have implicated 
elevated defensin levels during episodes of BV with an increased risk for preterm labor[42, 47].  
Whether these defensins play an active part in initiating preterm labor, or are a marker of some 
other event (such as neutrophil influx) remains unclear.  Figure 1.2 is a proposed model for how 
BV is linked to preterm labor.   Interestingly, despite the association of increased 
proinflammatory cytokines, BV is not a state characterized by high proinflammatory cytokine 
production (IL-8, IL-6, and TNFα) in vaginal fluids[48-51],  and attempts to treat the infection 
and limit the incidence of preterm labor have been highly unsuccessful[52-57].  This is 
suggestive of a state that precedes BV which is high in proinflammatory cytokines that is the 





Figure 1.2 Proposed model for link between bacterial vaginosis and preterm birth 
1.3 Identification of a novel Lactobacillus species, Lactobacillus iners 
Although the dominance of vaginal lactobacilli has been noted for over a century, culture 
independent techniques continue to expand our knowledge.  Recently, the use of these 
12 
 
techniques expanded the repertoire of lactobacilli to include a novel species, L. iners[58].  This 
species has subsequently been shown to be a common constituent of the vaginal tract[59, 60], 
and in fact is the dominant species in approximately 30% of women[9].  Although ubiquitous in 
the vaginal tract, this organism was initially overlooked because the media used to isolate 
vaginal lactobacilli, de Man-Rogosa-Sharpe (MRS) agar[61], does not support the growth of L. 
iners.  This inability to grow on media used to support most lactobacilli foreshadowed the 
unique and strange behavior of this organism in the vaginal tract.       
1.3.1 Taxonomy and Physiology 
Figure 1.3 shows a phylogenetic tree demonstrating the relatedness of L. iners to other 
lactobacilli.  Like other lactobacilli, this organism is a Gram positive, facultatively anaerobic rod.  
Growth did not take place on MRS agar, and required blood agar.  Interestingly, unlike other 
vaginal lactobacilli, this organism is noticeably shorter and fatter[58].  The genome of this 
organism is significantly reduced, being the smallest Lactobacillus genome to date with a single 
chromosome of approximately 1.3Mbp.  Contained within the genome are several proteins 
which contribute to its ability to persist in the vaginal tract: several alkaline shock proteins as 
well as alternative sigma factors which aid in tolerating altered pHs as well as stress associated 
with infection.  The genome also possesses iron-sulfur cluster assembly systems which are 
important for moving iron and sulfur to the appropriate locations within the cell as well as 





Figure 1.3 Phylogenetic relationships between L. iners and other Lactobacillus species 
1.3.2 Role in the Vaginal Tract  
Although this organism is a member of the genus Lactobacillus and closely related to other 
vaginal lactobacilli, it seems to lack the protective effects traditionally ascribed to this group.   
Ravel et al. demonstrated that women with a microbiota dominated by this organism showed 
elevated and variable pH as well elevated and variable Nugent scores as compared to an L. 
crispatus dominated microbiota which had a lower and more homogenous pH and Nugent 
score profile.  This large study suggests that a microbiota that is dominated by L. iners is less 
stable, and more prone to alterations of its composition, as would be seen with BV.  It has also 
been suggested that L. iners represents a transitional species, present after treatment with 
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antibiotics[63] or after administration of exogenous estrogen[64].  Given that 70% of women 
who are treated for bacterial vaginosis will recur, the dominance of L. iners post treatment 
suggests that this organism contributes in some way to an imbalance in the vaginal tract.  
Several groups have taken this link one step further, to demonstrate an association between 
the presence of L. iners and the presence of other BV associated organisms[65].  This result is 
also consistent with other published work demonstrating that L. iners persists during episodes 
of BV, a condition in which Lactobacillus species are normally lost.  While this does not 
necessarily link L. iners to causing changes in the vaginal microbiota, it is peculiar that this 
organism shows a positive association with BV associated microbiota.  All of these data are 
further supported in a study by Srinivasan et. al, where it was demonstrated that the presence 
of L. iners is not associated with the absence of BV [36].  Another clear demonstration of the 
ability of L. iners to stimulate alterations of the microbiota was a study which examined the 
microbiota of pregnant women over time as a function of Lactobacillus status.  In this cohort, 
they demonstrated that women with a vaginal micromicrobiota dominated by L. iners had a 
tenfold increased risk for conversion to an “abnormal vaginal micromicrobiota” as indicated by 
Gram stain[66].  While there is much to learn about the physiology of this organism and its role 
in the vagina, these data suggest that this organism does not adhere to the traditional view of 
vaginal lactobacilli as stabilizing, protective species.   
1.4 Bacterial toxins 
A wide variety of pathogenic organisms produce toxins.  Broadly, toxins can be characterized as 
endotoxin and exotoxins.  Endotoxins are a common feature of all Gram negative organisms, 
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and are non-proteinaceous components of the cell wall.  The major endotoxin present in Gram 
negatives is Lipopolysaccharide (LPS), and is released as bacteria die and lyse.  These endotoxins 
are able to activate the immune system via toll-like receptors (TLRs), resulting in cytokine 
release which, left uninhibited can result in fever, shock, and death.  The other major classes of 
toxins are the exotoxins.  These proteins are a group of proteinaceous toxins which are 
secreted by the organisms in response to a number of cues.   In characterizing their activity, we 
can broadly classify exotoxins into three categories: those which act intracellularly (which 
includes cholera toxin and diphtheria toxin) and have enzymatic activity, those which have 
membrane damaging activity (including the CDCs), and those which are able to 
activate/stimulate the immune system inappropriately (pyrogenic exotoxins).  These toxins play 
important roles in the pathogenesis of the organisms which produce them, conferring some 
sort of advantage over the host.  The best known and studied toxin is diphtheria toxin, 
produced by Corynebacterium diphtheria.  First discovered in 1888 by Yersin and Roux, this 
toxin is of the A/B type, which possess two components.  For this group of toxins, the toxic 
activity is contained within the A subunit, and the B subunit is involved in binding to target cells 
and delivering the A subunit intracellularly.  Diptheria toxin is secreted as a single 
polypeptide[67] and the B subunit interacts with heparin binding protein[68] which is then 
internalized via receptor mediated endocytosis.  The A subunit possesses ADP-
ribosyltransferase activity and transfers an ADP-ribose group on to elongation factor 2 (EF2), 
which results in inhibition of protein synthesis and ultimately localized cell death[69].  The 
membrane damaging toxins can destabilize membranes in a variety of ways: enzymatic activity 
against membrane lipids (exemplified by α-toxin of C. perfringens which has phospholipase C 
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activity), toxins with surfactant like activity allowing disruption of membranes (such as delta 
toxin of S. aureus)[70], and those which produce holes in cell membranes resulting in leakage of 
intracellular contents,  influx of water, and ultimately cell lysis.  This latter class, the pore 
forming toxins, are the largest class of bacterial toxins and are often important virulence 
factors[71].  These toxins are secreted as monomeric proteins, interact with target membranes 
via a membrane receptor, and then oligomerize to form the pore.  This ability to diffuse within 
the lipid bilayer and oligomerize is the unifying feature of this class of toxins[72].  The PFTs can 
be categorized as α-PFTs and β-PFTs, based on the secondary structure utilized for membrane 
insertion.  The α-PFTs insert amphipathic α helices into the membrane whereas β-PFTs insert an 
amphipatic β- barrel structure into the membrane[73].  For a more in-depth understanding of 
the α-PFTs, see the reviews cited here[74, 75].  The cholesterol dependent cytolysins are a 
major group within the larger family of β-PFTs and are discussed further below. 
1.4.1 Regulation of toxin activity  
Toxin activity is important for the pathogenesis of many organisms, conferring some advantage 
over the host.  However, production of these bacterial toxins can be energetically costly, and 
often toxin production is required only at a particular time in the life cycle of the organism.  
Regulation of toxin activity can occur at the level of expression or post-translationally at the 
level of the function of the protein itself.  Throughout the class of bacterial exotoxins, 
regulation can occur at both of these levels.  Outlined here are just a few examples, to provide 
some context for studies carried out here examining regulation of CDC activity.  As mentioned 
above, diphtheria toxin is one of the most widely studied toxins, and demonstrates regulation 
not only at the level of transcription but also at the level of activity of the protein itself.  
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Expression of diphtheria toxin is regulated by the availability of iron.  When iron is abundant, 
the DtxR protein is expressed.  This protein can then bind to regulatory sequences upstream of 
the tox gene encoding diphtheria toxin, preventing transcription[76, 77].  A similar mechanism 
has been noted for Shiga toxin as well as Shiga-like toxin[78].  Despite the sequencing of a 
number of CDC genes and their surrounding regions, no known regulatory sequences have been 
identified for these toxins.  To date, no one has reported any environmental regulation of CDC 
expression, except for the CDC produced by B. anthracis[79].  At the level of actual protein 
function, pH can be an important regulator of toxin activity.  This has been demonstrated for 
diphtheria toxin, where acidic pH has been shown to facilitate translocation of the toxin from 
the acidified endosome into the cytoplasm.  Structural studies have demonstrated that upon 
exposure to acidic pH, conformational changes take place in the protein which “activate” the 
protein, exposing regions which will insert into the membrane[80].  The activity of some 
members of the CDC family (PFO and LLO) have been shown to be regulated by pH as well.  The 
role that pH plays in regulating the activity of these CDCs is discussed further below.  Overall, 
pH seems to be an important regulator of activity of bacterial toxins, and is investigated in the 
work presented here.    
1.5 Cholesterol Dependent Cytolysins (CDCs) 
The CDCs are a family of pore-forming toxins belonging to a larger class of β-barrel pore 
forming toxins.  These β-PFTs are distinguished from the other major class of PFTs, the α-PFTs,  
by their use of amphipatic β-hairpins to create a β-barrel structure.  The CDCs are distinguished 
within this larger group because of their absolute requirement for cholesterol in target 
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membranes, making them specific for eukaryotic cells.  This unifying characteristic has been 
demonstrated in several studies as toxin activity can be inhibited by the addition of exogenous 
cholesterol[81] as well as by the depletion of membrane cholesterol[82].  Additionally, they are 
known to form extraordinarily large pores in target membranes, with diameters exceeding 
15nm.   
The events of pore formation and their molecular mechanisms have been extensively 
investigated over the past 50 years, and while a more complete picture has emerged, there is 
still much that is unknown about the pore formation and toxin activity.  As noted before, there 
is an absolute requirement for cholesterol in target membranes, which affords these toxins a 
cellular receptor.  Interestingly, a few toxins have been identified that require cholesterol for 
activity, but make use of an additional protein receptor to mediate initial membrane binding 
activity. These toxins, Vaginolysin (VLY) and Intermedilysin (ILY), and the revised role of 
cholesterol in pore formation will be discussed later.  Upon membrane binding, an elegant and 
concerted series of events results in the oligomerization of monomeric toxins into a pore 
structure, leading to cell lysis. 
 
The first CDCs were discovered more than a century ago [83] and as the number of cultivatable 
organisms grows and methods for looking at the genomes of cultivated and uncultivated 
organisms grows, we have greatly expanded the family to include 25 members produced by 
Gram positive organisms (Table 1.1).  These toxins play crucial roles in the pathogenesis of 
diseases caused by these organisms and are required in various stages/roles in disease 
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progression.  Initially thought to be a feature unique to Gram positive organisms, recent work 
has demonstrated the identification of two putative CDCs in two Gram negative organisms, 
desulfolysin (DLY) and enterolysin (ELY)[84].  Interestingly, unlike the Gram positive CDC 
producing organisms, for which the human body is a physiological niche, the Gram negative 
CDC producing organisms predominantly inhabit sediments and soils.  This finding suggests 
roles in more than just disease pathogenesis, but also in protection against eukaryotic 
predators.   
Whatever the role these toxins may play, a deeper understanding of these toxins and the 
mechanisms by which they make pore is critical to developing targeted therapies to combat 
these toxins.  With the increasing emergence of antibiotic resistance and a better appreciation 
for the crucial protective role the normal micromicrobiota plays in health, it has become 
increasingly important to tailor therapies to these crucial virulence factors.  These targeted 
therapies can disarm the offending organisms, while preserving the normal micromicrobiota 









Table 1.1 Family of Cholesterol Dependent Cytolysins (CDCs) 
 
Table 1.1 The Family of Cholesterol Dependent Cytolysins 
 
1.5.1 Monomer Structure 
CDCs are secreted as water soluble monomers, and range in size from about 50-60kDa.  These 
protein toxins all show high identity and similarity at the primary amino acid level, ranging from 
Bacterial genus Species CDC Abbreviation
Gram Positive
Arcanobacterium A. pyogenes Pyolysin PLO
B. alvei Alveolysin ALY
B. anthracis Anthrolysin O ALO
B. cereus Cereolysin O CLY
B. laterosporus Latersporolysin LSL
B. thuringensis Thuringiolysin O TLO
C. bifermentans Bifermentolysin BFL
C. botulinum Botulinolysin BLY
C. chauvcei Chauveolysin CVL
C. histolyticum Histolyticolysin O HTL
C. novyi type A Novyilysin O NVL
C. perfringens Perfringolysin O PFO
C. sordellii Sordellilysin SDL
C. septicum Septicolysin O SPL
C. tetani Tetanolysin TLO
Gardnerella G. vaginalis Vaginolysin VLY
L. ivanovii Ivanolysin ILO
L. monocytogenes Listeriolysin O LLO
L. seeligeri Seeligerolysin LSO
S. canis Streptolysin O SLO
S. equisimilis Streptolysin O SLO
S. intermedius Intermedilysin ILY
S. pneumoniae Pneumolysin PLY
S. pyogenes Streptolysin O SLO
S. suis Suilysin SLY
Gram Negative
Desulfobulbus D. propionicus Desulfolysin DLY







40-70%[85].  Given this high degree of identity, it is likely that this entire family of toxins fold 
into similar three dimensional structures.  Much of the structural data we have is based on PFO, 
and to date, only two of the members in this entire family have been crystallized, the other 
being ILY.  Overall, CDC monomers have a four domain structure, which is discontinuous.  Much 
work has been done in assigning various functions to each of these domains.  While certain 
activities are localized to particular domains, it is very clear that individual domains are in 
communication with each other and pore formation requires concerted events between 
domains for functional pore formation.  The most highly conserved portion of the protein is at 
the C-terminus, an 11 amino acid stretch known as the undecapeptide, or Trp-rich region.  
Figure 1.4 shows a comparison of the region in several members of this family.  The 






Figure 1.4 Comparison of the undecapeptide region 
1.5.2 Mechanism of pore formation 
Fig 1.5 shows the overall process of pore formation for the cholesterol dependent 
cytolysins[86].   
Figure
 
1.5 Model of CDC pore forming mechanismDC pore forming mechanism 
1.4.2.1 Membrane Binding 
As mentioned previously, for most of the CDCs (with the exception of ILY and VLY) cholesterol 
serves as the receptor for initial membrane interaction.  Various pieces of evidence have 
implicated domain 4 in this membrane binding activity, and over the years the data has 
suggested different portions of this domain to be implicated in this activity, much of which was 
localized to the undecapeptide region.  One group demonstrated modification of the conserved 
cysteine residue (in all CDCs except PLO and ILY) resulted in reduced membrane binding 
23 
 
activity[87].  It was later determined that this cysteine residue was not necessarily involved in 
membrane binding, but upon oxidation was then blocked by undefined molecules from the 
culture medium or from bacterial metabolism.  Additional studies targeted the tryptophan 
residues present in the undecapeptide.  The mutation of these residues initially seemed to alter 
membrane binding[88].  Additional studies revealed that rather than being involved in initial 
membrane binding to cholesterol in target membranes, these residues were important for 
initiating conformational changes in the protein that were important for pore formation.  The 
actual portion of the protein which mediated cholesterol binding remained elusive until a study 
by Soltani et. al [89] demonstrated the importance of three hydrophobic loops L1-L3 in 
mediating cholesterol binding  in target membranes.  Further study into the mechanisms of 
membrane recognition then identified the cholesterol recognition motif (CRM) as a Threonine-
Leucine pair in loop 1 which was found to be conserved in all known CDCs[90] .  Figure 1.6 







Figure 1.6 Comparions of the L1 loop in several known CDCsFigure 1.6 Comparison of the L1 loop in severalknown CDCs 
 
1.4.2.2  Oligomerization 
After membrane binding, the next step in the process of pore formation is oligomerization.  For 
some time, it was unclear whether insertion of transmembrane helices in the protein occurred 
before or after oligomerization of monomeric toxin.  After much examination, several groups 
using fluorescent probes and disulfide trapping [91] as well as modulating the temperature[92] 
confirmed the correct sequence of events.  Upon membrane binding, via this Thr-Leu pair, 
membrane insertion of L2 and L3 as well as the undecapeptide occurs.  It was initially thought 
that this was the region that then contributed to the final formation of the pore[93].  However, 
it was later shown that this region, although inserting did not embed itself deeply into the 
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membrane making it unlikely to be the portion which contributed to the final pore.  This 
insertion event is crucial to pore formation, but because it then initiated further structural 
changes in the protein, not because it contributed anything to the ultimate pore structure.  
Specifically, the insertion of this protein then maintains the monomer in an orientation 
perpendicular to the membrane[94-96].  Additionally, insertion of the arginine residue present 
at the end of the undecapeptide is crucial for coupling membrane binding to the structural 
changes needed for the oligomerization process.  Specifically, upon insertion of the 
undecapeptide, and this arginine residue, changes are transmitted to D3 of the protein, and 
specifically to the four β sheets that contribute to the final pore. The β4 sheet is normally not 
exposed due to hydrogen bonding to a short hydrophobic region termed the β5 loop.   Upon 
membrane binding, insertion of a tryptophan in domain 3 into the membrane initiates the 
movement of the β5 loop away from the β4 sheet by virtue of a flexible glycine linker[97].  This 
exposes β4 which then allows it to interact with the exposed surface of the β1 sheet allowing 
for oligomerization into a prepore complex[98].  Figure 1.7 shows the proposed mechanism for 
these structural changes[99].  This prepore however must undergo further structural changes 







Figure 1.7 Membrane binding initiates conformation changes promoting oligomerization 
1.4.2.3 Pore Formation 
The rate limiting step for pore formation is the formation of this prepore complex.  Studies 
using disulfide locked mutants demonstrated that toxins could oligomerize on the surface, and 
upon reduction of the disulfide, pore formation proceeded with faster kinetics then if these 
toxins were pre-reduced in solution before being incubated with membranes[91].  The 
interaction between adjacent monomers is crucial to the final steps of pore formation: the 
disruption of the domain 2 and domain 3 interface, and insertion of the transmembrane helices 
(TMHs) present in domain 3.  The events between oligomerization and insertion of TMHs have 
not been completely worked out, but it is clear that monomers must align their transmembrane 
helices and in a concerted manner insert these TMHs to produce the final pore[100].       
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1.5.3 Properties of Specific Cholesterol Dependent Cytolysins 
Despite the high level of sequence similarity/identity and the seemingly similar mechanisms of 
action, further study of these toxins has demonstrated the evolution of specific and unique 
activities to the members of this family.  The unique characteristics of a few of these toxins are 
outlined below. 
1.5.3.1 Listerolysin O (LLO) 
Listeriolysin O (LLO) is the cholesterol dependent cytolysin produced by L. monocytogenes.  This 
organism is particularly interesting as it is one of the few CDC producing organisms known to 
have an intracellular lifestyle.  Various studies have demonstrated the importance of this pore 
forming toxin in phagosomal escape[101, 102], and intracellular survival and replication.  This 
toxin has evolved specific mechanisms making it perfectly suited to its intracellular lifestyle, 
operating maximally at acidic pH and rapidly losing activity at neutral pH, as would be 
experienced upon escape from the acidified phagosome and into the more neutral cytosol.  
Extensive investigation has led to the identification of a triad of acidic residues in domain 3 of 
the protein.  This triad of charged residues acts a sensor, detecting an increase in pH and 
causing a rapid and irreversible unfolding of the protein and loss of activity[103].  The 
importance of this pH dependent activity has been shown to be crucial to the lifestyle of this 
organism, as replacement with the pH “insensitive” toxin, PFO, completely inhibited the growth 




1.5.3.2 Perfringolysin O (PFO) 
Perfringolysin O is perhaps one of the most studied CDC and is the basis for many of the 
structural studies that have been carried out to date.   Given that it is one of two toxins in this 
family which have been crystallized and for which the structure has been solved, it forms the 
logical basis for a number of studies examining structural aspects of the pore forming 
mechanism.  Recently, this organism was shown to possess an intracellular component to its 
lifestyle[104].  As with LLO, this toxin has also evolved mechanisms making it well suited to its 
role in the acidified phagosome, showing enhanced activity at low pH. Unlike LLO, this toxin 
maintains hemolytic activity at more neutral pH, and to date the mechanism for this 
enhancement at low pH has not been elucidated.  It has been suggested that the enhancement 
of activity at low pH is due to a partial unfolding event of the TMHs that primes the protein for 
membrane insertion[105].   
1.5.3.3 Vaginolysin (VLY) 
VLY is the CDC produced by the vaginal bacterium (and potential pathogen) G. vaginalis.  It is 
hypothesized that this organism (and its toxin) plays a role in the pathogenesis of bacterial 
infections, specifically in the etiology of bacterial vaginosis (BV).  This toxin was initially 
identified in crude extracts of bacterial preparations of G. vaginalis.  Despite possessing 
characteristics comparable to that of PFO, this toxin was initially thought not to be a part of the 
CDC superfamily as it was inactivated by β-mercaptoethanol[106].  It was later discovered, after 
genomic data became available and recombinant protein was produced, that the basis for this 
was the absence of the cysteine residue in the undecapeptide region.  This toxin, as well as 
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Intermedilysin produced by Streptotoccus intermedius, represents the species specific members 
of the cholesterol dependent cytolysin superfamily, showing a restriction for human derived 
targets[26].  The basis for this was discovered to be an alteration in the molecule that mediated 
initial interaction with target membranes.  While it is accepted that the non-species specific 
toxins utilize cholesterol to mediate initial membrane interactions, the human specific toxins, 
VLY and ILY, utilize the GPI linked protein CD59 to mediate membrane recognition.  
Interestingly, despite the initial interaction being mediated by this protein receptor, cholesterol 
is absolutely crucial to the activity of the protein, and it has been shown that the Thr-Leu pair 
which mediates cholesterol recognition is conserved in these species specific toxins.   
1.5.3.4 Streptolysin O 
Streptolysin O is produced by several members of the genus Streptococcus.  This toxin 
possesses several of the features common to the non-species specific CDCs, including an 
invariant undecapeptide sequence (ECTGLAWEWWR) and the conserved Thr-Leu pair which 
mediates cholesterol binding.   It has been most extensively studied in the context of S. 
pyogenes infection, which is mainly associated with wound infections.  This toxin is the largest 
member of this family, on the basis of primary amino acid sequence, with 571 residues.  This 
toxin was crucial in suggesting that CDCs do more than just punch holes in target membranes 
and cause cell lysis.  It was discovered that SLO, after pore formation translocated the bacterial 
protein NADH-glycohydrolase into the target cells, and this required an N-terminal region that 
was missing in all other CDCs[107, 108].  To date, translocation of other factors or translocation 
30 
 
by other toxins has not yet been demonstrated, although it has been shown that the pore can 
facilitate the translocation of peptidoglycan (but probably not in a specific manner)[109] 
 
1.5.3.5 Pneumolysin 
Pneumolysin (PLY) is produced by the Gram positive organism Streptococcus pneumoniae.  This 
organism is responsible for a number of different diseases including pneumonia, meningitis, 
and otitis media.  The importance of this virulence factor to disease pathogenesis has been 
highlighted in several studies[110-113].  Unlike other members of the cholesterol dependent 
cytolysin family, this toxin lacks the N-terminal secretion signal.  PLY is seen to accumulate in 
the cytoplasm of the bacterium and is released upon autolysis of the cell.  PLY is also unique in 
its ability to activate complement[114].  Interestingly, unlike many other toxins, PLY can form 
oligomeric structures in solution with no exogenous membranes or cholesterol.  The 
importance of this activity in disease pathogenesis is not yet clear.   
 
1.6 Statement of Hypothesis 
 Lactobacillus iners is a newly identified constituent of the vaginal tract.  Lactobacillus 
species are thought to provide a protective effect within the vaginal tract, maintaining proper 
pH and preventing overgrowth by potentially pathogenic species.  Epidemiological data 
suggests that Lactobacillus iners rather than contributing to stability of the vaginal tract may 
actually contribute to alterations of the vaginal microbiota (as seen in BV).  Furthermore, 
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attempts to treat BV and limit the adverse outcomes associated with it have been highly 
unsuccessful.  Given L. iners ability to persist in both BV and non-BV states, as well as its 
association with increased incidence of BV, we speculate that L. iners has pathogenic potential 
and can contribute to BV pathogenesis and BV associated outcomes.  We sought to identify and 
characterize virulence factors produced by L. iners and understand their role in BV and BV 
associated preterm labor. Specifically we, 
1. Identified and characterized a putative pore forming toxin produced by Lactobacillus 
iners described in Chapter 2 
2. Investigate the mechanism by which activity of this toxin is regulated described in 
Chapter 3 
3. Characterize the responses of the vaginal epithelium to the bacteria and its toxin 










Chapter 2: Identification and Characterization of Inerolysin, the Cholesterol Dependent 
Cytolysin produced by Lactobacillus iners 
 
Adapted from Rampersaud et. al (2010) 
2.1 Introduction 
The cholesterol-dependent cytolysins (CDCs) are a family of protein toxins produced by a wide 
range of Gram-positive bacteria. CDCs share several characteristics, including a four- domain 
structure, a requirement for membrane cholesterol for efficient activity, and an ability to form 
large pores in host cells, exceeding 150 Å in diameter[86]. In general, soluble CDC monomers 
are secreted into the extracellular environment and bind to target cell membranes through 
direct recognition of cholesterol or, in the cases of the human-specific toxins vaginolysin (VLY) 
from Gardnerella vaginalis and intermedilysin (ILY) from Streptococcus intermedius, via 
recognition of human CD59 on the target cell surface[26, 115].  Following membrane 
association, CDCs oligomerize to form a prepore structure, a process that is dependent upon 
the availability of cholesterol [89, 99, 115, 116].  In many cases, CDCs are required for virulence 
for their cognate organisms, and rather than acting solely as cytolytic toxins, CDCs may have 
more sophisticated roles in disease pathogenesis [102, 117, 118]. Understanding CDC evolution 
and host specificity is of considerable interest and has been limited by incomplete knowledge of 
the diversity of the CDC family. In particular, characterization of cytolysins most closely related 
to those in which host specificity has evolved may provide additional insights into the 
mechanism and effects of such restriction.  Lactobacillus iners is a relatively recently recognized 
member of the human vaginal microbiota[58-60] that was initially overlooked because of its 
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inability to grow on de Man- Rogosa-Sharpe agar, which is normally used to isolate vaginal 
lactobacilli. In healthy women, the vaginal microbiota is dominated by Lactobacillus species, 
with L. crispatus, L. gasseri, and L. jensenii being the most commonly cultivated[119]. These 
organisms are thought to play a role in resistance of the vaginal tract to colonization by 
pathogens, possibly through the production of lactic acid. L. iners is unusual among lactobacilli 
in that it may be detected during bacterial vaginosis (BV), a state in which G. vaginalis generally 
predominates and other Lactobacillus species are only rarely found at the vaginal mucosal 
surface[63, 66, 120, 121]. More recently, culture-independent studies of the vaginal microbiota 
have demonstrated that L. iners vaginal colonization may be considerably more prevalent than 
previously recognized, and in some cases it may be the most abundant organism detected[122, 
123].  Other sequenced Lactobacillus strains lack identifiable CDC genes. Given the unusual 
biology of L. iners and its similarities to G. vaginalis, we performed a bioinformatic search for 
genes that might encode a CDC in the L. iners genome. Here we report the identification, 
cloning, and characterization of inerolysin (INY), the L. iners CDC. The description of INY 
expands the CDC family to include a nonspecific toxin with the greatest sequence similarity to 
VLY and ILY, the two species- specific members of the CDC family. Further study of this newly 
identified CDC will increase our understanding of the evolution of the CDC family and the role 




2.2 Materials and Methods 
2.2.1 Bacterial strains and cell lines  
L. iners strains were grown on human blood bilayer-Tween agar. L. iners type strain DSM 13335, 
the genome of which has been sequenced, was obtained from the Deutsche Sammlung von 
Mikroorganismen und Zellkulturen. L. iners clinical isolates CCUG38955A, CCUG44023, 
CCUG44137, CCUG44284, CCUG46933, CCUG28746, CCUG32387, CCUG24626, and 
CCUG35443B were obtained from the Culture Collection of the University of Göteborg.  L. iners 
strain ATCC 55195 was obtained from the American Type Culture Collection. Eukaryotic cell 
lines HeLa (ATCC CCL-2) and COS-7 (CRL-1651) were maintained in minimum essential medium 
(MEM) supplemented with 10% fetal bovine serum (Invitrogen), 1 mM sodium pyruvate, and 10 
g/ml ciprofloxacin. 
 
2.2.2 Cloning and expression of CDCs 
The open reading frame (ORF) containing INY lacking its predicted signal sequence was 
amplified by PCR from L. iners DSM 13335 genomic DNA using primers NheI-INY-F 
(GCCGCCGCTAGCA ATACTGAGCCAAAAACAGCTATTG) and XhoI-INY-R (GCCGCCCTCG 
AGTTAGTCATTTTTTACTTCTTCTTTG; restriction sites are underlined). The pneumolysin (PLY) ORF 
was amplified from Streptococcus pneumoniae strain D39 genomic DNA using primers NdeI-
PLY-F (GCCGCCC ATATGGCAAATAAAGCAGTAAATGAC) and PLY-R-XhoI (GCCGCCCT 
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CGAGCTAGTCATTTTCTACCTTATCTTC). The products were cloned via the indicated restriction 
sites into the pET28a vector (Novagen) in order to generate N-terminally hexahistidine- tagged 
constructs, verified by sequencing, and transformed into T7 Express Iq competent E. coli (New 
England BioLabs).  Expression strains were grown in LB with 50 g/ml kanamycin for 5 h, and 
protein expression was induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 4.5 
h. Bacterial cells were pelleted by centrifugation and lysed in a buffer (50 mM NaH2PO4, 300 
mM NaCl, 10 mM imidazole) containing a protease inhibitor cocktail and Benzonase nuclease. 
Lysates were cleared by centrifugation, and supernatants containing His-tagged proteins were 
purified with Ni-nitrilotriacetic acid agarose beads (Qiagen) according to the manufacturer’s 
instructions. Purified proteins were dialyzed against lipopolysaccharide-free phosphate-
buffered saline (PBS) with 1 mM CaCl2 and 1 mM MgCl2 overnight at 4°C, and protein 
concentrations were determined by a modified Bradford assay (Bio-Rad). 
 
2.2.3 Detection of the INY gene in isolates of L. iners  
The presence of the gene for INY in several clinical isolates of L. iners was detected by PCR from 
genomic DNA using primers INY-test-F (CAGCAACACCTGGGTTAGAACTATC) and INY-test-R 
(CAGGTGCTCTTTTCAAGGCAGAC), targeting an internal region of the INY ORF. Amplification was 




2.2.4 Bioinformatic analysis 
Protein sequence prediction and alignment were carried out using MacVector software (version 
11; MacVector Inc.). Other sequences were obtained from the GenBank/Entrez Protein 
database (National Center for Biotechnology Information [NCBI]). N-terminal signal sequences 
were predicted with SignalP (version 3.0, available at http://www.cbs.dtu.dk 
/services/SignalP/)[124].   Alignments for phylogenetic analysis were done in BioEdit v7.04 (Ibis 
Therapeutics) using ClustalW for amino acids and then toggled back to nucleotides for further 
analysis. 
 
2.2.5 Phylogenetic analyses 
Phylogenetic analyses were performed using three methods: neighbor joining (NJ), maximum 
parsimony (MP), and maximum likelihood (ML). The optimal trees obtained by all of these 
techniques were almost identical. NJ analysis was done with PAUP[125] by using the minimum 
evolution criterion, allowing branch length to be negative except when calculating tree scores 
(for which they were set to zero) and breaking ties randomly. MP analyses were also done in 
PAUP using 1,000 random addition (RA) steps, followed by tree branch reconnection (TBR) 
swapping using the Multrees option in PAUP. Gaps were treated as a state, and all characters 
and state transformations were weighted equally. Bootstrap values were calculated using 100 
bootstrap iterations using 100 replicates of RA, followed by TBR, in each iteration. ML analyses 
were performed with RAxML Blackbox (http://phylobench.vital-it.ch/raxml-bb/index .php) 
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using a GTRGamma I model. Node support was assessed with 100 rapid bootstrap replicates 
using RAxML. 
 
2.2.6 INY Western blotting 
The indicated L. iners strains were grown in Columbia broth with 5% defibrinated sheep blood 
and 10% fetal bovine serum for 2 days at 37°C in 5%CO2. Bacterial cells were pelleted by 
centrifugation and lysed with BugBuster Protein Extraction Reagent (Novagen) containing 
Benzonase nuclease. Supernatants were concentrated from 5 ml to 500 μl using an Amicon 10-
kDa centrifugal filtration device (Millipore). Supernatants were run on a 4 to 12% gradient 
polyacrylamide gel (Invitrogen). Proteins were transferred to polyvinylidene difluoride (PVDF) 
membrane, blocked with 5% milk, and probed with one of two murine anti-PLY monoclonal 
antibodies as indicated below (Santa Cruz Biotechnology, 1:1,000 dilution, or Novacastra, 
1:250,000 dilution). The primary antibody was detected with horseradish peroxidase-
conjugated anti- mouse IgG by enhanced chemiluminescence. 
 
2.2.7 Live-cell imaging of phalloidin entry into epithelial cells 
HeLa cells were grown to confluence on uncoated glass bottom culture dishes (MatTek) and 
washed in PBS with 1 mM CaCl2 and 1 mM MgCl2. Phalloidin-Alexa Fluor 568 (Invitrogen) was 
added to a final concentration of 3.3 nM, and the cells were treated with INY (final 
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concentration, 1.8 µg/ml) or a vehicle control. Images were acquired on a Zeiss Axio Observer 
inverted microscope with appropriate filters every 30 s.  
2.2.8 Erythrocyte lysis assays 
The use of human erythrocytes from healthy adult volunteers after verbal informed consent 
was obtained was approved by the Columbia University Institutional Review Board (protocol 
IRB-AAAC5641). Defibrinated sheep and horse blood was obtained from Fisher Scientific. 
Erythrocytes were washed in sterile PBS with 1 mM CaCl2 and 1 mM MgCl2. For endpoint 
assays, 100 µl of a 1% washed erythrocyte solution was mixed with 100 µl of toxin in a 96-well V 
bottom plate and incubated for 30 min at 37°C and 5% CO2. After 30 min, the plates were spun 
at 2,000 rpm to pellet erythrocytes. Supernatant was removed, and the optical density at 415 
nm (OD415) was measured. In the indicated experiments, the toxin was incubated with 
cholesterol dissolved in chloroform or with chloroform alone (vehicle control) for 10 min at 
room temperature before use. In some experiments, the assay was carried out in the presence 
of dithiothreitol (DTT) or a vehicle control. In the indicated experiments, toxin was incubated 
with polyclonal anti-VLY rabbit serum or preimmune control rabbit serum (25) on a rotary 
shaker for 20 min at 4°C. For the kinetic assay, absorbance at 700 nm was measured every 




2.2.9 LDH assay  
HeLa cells were grown to confluence in a 24-well plate and weaned from serum and antibiotics 
overnight. Cells were incubated with toxin diluted in MEM for the indicated time periods. A 
150-�l volume of supernatant was used to assay lactate dehydrogenase (LDH) release with the 
Cytotoxicity Detection Kit (Roche). The 100% lysis control was an identical well of HeLa cells 
concurrently treated with 1% Triton X-100 in MEM.  
 
2.2.10 Epithelial p38 MAPK phosphorylation 
HeLa cells were grown to confluence in a 24-well plate and weaned from serum and antibiotics 
overnight. Cells were incubated with CDCs diluted in MEM for the indicated time periods. Cells 
were lysed in radioimmunoprecipitation assay buffer (20 mm Tris [pH 7.4], 137 mM NaCl, 10% 
glycerol, 2 mm EDTA [pH 8.0], 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate [SDS]) with protease inhibitors and phosphatase inhibitor cocktail (Sigma), 
separated on a 4 to 12% polyacrylamide gel, and transferred to a PVDF membrane. Membranes 
were blocked in 5% milk in Tris-buffered saline–Tween 20, probed with phospho-p38 mitogen-
activated protein kinase (MAPK) antibody (Cell Signaling; 1:1,000), and detected with anti-
rabbit IgG (1:5,000) by enhanced chemiluminescence. Blots were stripped in 4 N NaOH for 30 




2.2.11 Statistical analyses 
Hemolysis assay results are expressed as average values from six readings from one 
representative experiment. Each experiment was repeated three times. Data were analyzed by 
one-way analysis of variance, followed by Tukey’s posttest. For the antibody protection assay, 
the data shown are from one representative experiment. Data were analyzed by Student t test. 
A P value of 0.05 was considered significant. All statistical analyses were carried out using Prism 
4 software (GraphPad) 
 
2.2.12 Nucleotide sequence accession numbers 
The accession number for INY from L. iners DSM 13335 is ZP_05744302 (annotated as 
perfringolysin O).  Protein sequence data for PLY from S. pneumoniae TIGR4, R6, and 
Taiwan19F-14 are available from the NCBI under accession numbers AAK75991, AAL00542.1, 
and ACO23064.1, respectively. Other NCBI accession numbers are as follows: VLY from G. 
vaginalis ATCC 14019 and ATCC 14018, ACD39460 and ACD39459, respectively; ILY from S. 
intermedius UNS38 and UNS46, BAE16324 and BAA89790, respectively; LLO from L. 
monocytogenes NICBP 54006, ACF40759; ivanolysin (IVN) from Listeria ivanovii 16328, P31831; 
anthrolysin O (ALO) from Bacillus anthracis A0248, YP_002867524; cereolysin (CER) from 
Bacillus cereus B16, AAX88798; mitilysin (MLY) from Streptococcus mitis R5II, ABK58696; 
suilysin (SLY) from Streptococcus suis 3, CAC94852; perfringolysin O (PFO) from Clostridium 
perfringens 13, NP_561079; alveolysin (ALV) from Paenibacillus alvei, AAA22224; pyolysin (PYO) 
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from Arcanobacterium pyogenes BBR1, AAC45754. Corresponding nucleotide sequences were 
obtained from records linked to these amino acid sequences. 
 
2.3 Results 
2.3.1 The genome of L. iners contains a putative CDC 
 A basic local alignment search of the draft L. iners DSM 13335 genome sequence revealed an 
ORF with 51.9% identity and 68.4% similarity to VLY, the G. vaginalis CDC. This ORF was not 
found in available genome sequences from other Lactobacillus species (data not shown). The 
ORF contained a predicted signal sequence with a predicted cleavage site between amino acids 
31 and 32. Primers were created to amplify a region in the ORF from DSM 13335 and were 
subsequently used to detect the presence of this putative CDC in the genomes of several other 
clinical isolates of L. iners (Fig 2.1A). A band of approximately 700 bp was detected after PCR of 
each of the 11 L. iners strains tested, indicating that the presence of this putative toxin is 
common to this species and not solely a feature of DSM 13335. The predicted amino acid 
sequence of INY exhibits sequence similarity and identity with diverse CDC family members 
(Table 1), with the greatest similarity to ILY and VLY, the human-specific CDCs. The nucleotide 
sequences of INY were used to generate phylogenetic trees by the NJ, MP, and ML methods, all 
of which displayed essentially the same topology (Fig 2.1B). These trees demonstrated that the 
putative CDC produced by L. iners falls into the Streptococcus CDC group including PLY and ILY 
and is more distantly related to CDCs from Listeria, Clostridium, and Bacillus. All 11 of the INY 
sequences were on a single branch with bootstrap support of 100%.The predicted INY ORF from 
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L. iners DSM 13335 was cloned into the pET28a expression vector in order to generate an N-
terminal hexahistidine fusion, and recombinant INY (rINY) protein was purified. SDS-
polyacrylamide gel electrophoresis analysis revealed a protein with a size of approximately 55 
kDa (Fig 2.2A). By Western blotting, INY was detected using a monoclonal antibody directed 
against PLY (Fig 2.2B), as well as a polyclonal antibody against VLY (data not shown). In order to 
determine whether INY was produced and secreted, we assayed the culture supernatants of 
several L. iners strains for the presence of this putative CDC. A band consistent with the size of 
processed (lacking the signal sequence) INY was detected in the supernatants of all of the L. 
iners strains but not in the culture supernatant of E. coli (Fig 2.2C). Additionally, a higher-
molecular-weight band was detected in L. iners supernatants which may represent either 
unprocessed INY released upon bacterial lysis or INY that has undergone an unclear type of 
posttranslational modification. There was variation among the L. iners strains with respect to 















Table 2.1 Similarities and Identities of the primary amino acid sequen 
 












Table 2.1  Similarities and Identities of the primary amino acid 
sequences of INY and other CDCs
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Figure 2.2 The putative cholesterol dependent cytolysin, inerolysin, resembles other cholesterol dependent cytolysins 
2.3.2 INY is a functional broad-host-range cytolysin and is inhibited by anti-VLY antibody 
rINY lysed murine, ovine, and human erythrocytes in a dose-dependent manner (Fig 2.3A). This 
lack of species specificity was in contrast to the previously described human specificity of ILY 
(Fig 2.3B) and was consistent with the behavior of PLY from Streptococcus pneumoniae (Fig 
2.3C). Polyclonal anti-VLY antibody protected ovine erythrocytes from INY-mediated lysis in a 




 2.3 Recombinant INY shows non-species specific hemolytic activity consistent with other cholesterol 
dependent  
2.3.3 Cholesterol inhibits INY activity 
CDCs bind cholesterol through a mechanism dependent on a Thr-Leu pair located in CDC 
domain 4 (10). This Thr-Leu pair is conserved in INY (Thr-507 and Leu-508 in INY from strain 
DSM 13335). The presence of excess cholesterol inactivates CDCs (3, 12, 13, 19, 20, 32). 
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Exogenous cholesterol inhibited INY-mediated lysis of ovine erythrocytes in both endpoint and 
kinetic assays (Fig 2.4) 
 




2.3.4 INY activity is enhanced by DTT 
CDCs were formerly known as “thiol-activated cytolysins,” which denoted the increase in lytic 
activity seen in many CDCs in the presence of reducing agents[126-130]. Thiol activation is 
dependent on the sequence of the undecapeptide, a highly conserved 11-amino-acid sequence 
in domain 4. The consensus undecapeptide, ECTGLAWEWWR, has a cysteine residue in the 
second position. This cysteine residue must be maintained in a reduced state for full toxin 
activity. Both ILY and VLY have unusual undecapeptides that lack this cysteine. However, the 
predicted primary amino acid sequence of INY contains the consensus undecapeptide. Thus, we 
predicted that INY would be thiol activated. Addition of DTT to a concentration of INY (200 
ng/ml) that brought about low-level (30%) lysis alone led to a modest increase in the efficiency 





Figure 2.5 Recombinant INY is a thiol-activated cytolysin 
2.3.5 INY forms functional pores in epithelial cells and activates proinflammatory signaling.  
L. iners colonizes the vaginal epithelium, and epithelial cells may represent a more 
physiologically relevant target for INY than erythrocytes. INY lysed human cervical epithelial 
(HeLa) cells in a dose-dependent manner, albeit at higher concentrations than those required 
for hemolysis (Fig 2.6A). This effect was not restricted to HeLa cells, as both COS-7 (Fig 2.6B) 
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and A549 (data not shown) cells were susceptible to INY-mediated lysis. Epithelial cells detect 
sublytic concentrations of pore-forming toxins and initiate p38 MAPK signaling through a 
mechanism dependent on sensation of osmotic stress (27). Consistent with the activity of other 
pore-forming toxins, INY activated p38 MAPK at sublytic concentrations (3 μg/ml) in both HeLa 
(Fig 2.6C) and COS-7 (Fig 2.6D) cells. Phalloidin, which is normally restricted from the interior of 
the cell, gains access to the cytoplasm of HeLa cells following treatment with INY (Fig 2.6E), 



















The vaginal mucosa is home to a complex ecosystem, with a microbiota that may remain stable 
over time or may undergo profound and rapid shifts, leading to disease states such as BV. 
Culture-based studies formed the foundation of our understanding of the vaginal microbiota, 
but more recent nucleic acid-based culture-independent investigations have deepened our 
understanding of vaginal ecology[60, 122, 123].   Most vaginal lactobacilli exert a protective 
effect and provide resistance to colonization by pathogens via the production of several anti- 
microbial substances. L. iners is an atypical organism recently identified as a member of the 
vaginal microbiota and may have pathogenic rather than (or perhaps in addition to) protective 
effects. We have characterized INY, a CDC family member and the first candidate virulence 
factor for L. iners.  At the primary amino acid sequence level, INY is most similar to the human-
specific CD59-dependent toxins VLY and ILY; however, its lytic activity is neither species nor cell 
type specific. A putative CD59 binding site has been reported for ILY [131], but this sequence is 
not present in VLY. Thus, an overall basis for CDC host specificity has not been defined. INY 
represents the nearest neighbor of the CD59-dependent CDCs and may serve as a useful tool 
for further evolutionary and functional comparisons. A hallmark of the unique biology of L. iners 
is its ability to continue to colonize the vagina under conditions under which other lactobacilli 
cannot, including during BV[36, 132]. INY is a thiol-activated, cholesterol-inhibitable toxin that 
is secreted by growing L. iners.   Sublytic concentrations of INY activate p38 phosphorylation in 
human genital tract epithelial cells. This is a conserved and tightly regulated response to 
membrane disruption and osmotic stress[133, 134].  INY pores are sufficient to allow entry of 
53 
 
molecules from the extracellular space into the cytoplasm, as demonstrated with fluorescent 
phalloidin (Fig. 6). This effect may be of particular importance in immune responses  
to polymicrobial colonization[109, 135].   Cytolysin production may provide defensive functions 
by killing professional immune cells, may make available new anatomic niches by disrupting  
epithelial barriers, or may allow bacteria to access sequestered sources of nutrients such as iron 
from within erythrocytes. We hypothesize that CDC secretion, a feature common to G. 
vaginalis and L. iners, may be an important factor in survival in the inhospitable environment of 
BV, though at the highest extremes of vaginal pH (6.0), INY may be inactive. Human α-
defensins, which inactivate CDCs[136], are  decreased during BV[137], and this deficiency may 
allow INY-mediated cellular damage to occur. Antibodies against other CDCs, including PLY and 
VLY, may bind and inhibit INY, as may host antimicrobial peptides.  Cauci et al. showed that 
local antitoxin IgA responses were correlated with mucosal cytokine levels and with BV 
diagnosis[138, 139]. Cross-reactivity between anti-VLY and anti-INY immunoglobulins may have 
implications for the efficiency of the host response to BV and for resolution of disease. The 
reversible deficiency of antimicrobial peptides observed in BV[137] may be important because 
of their antitoxin, as well as their antimicrobial, effects. Continued investigation of INY may help 






Chapter 3: Investigation into the pH dependent activity of INY 
 
3.1 Introduction 
The CDCs are a family of toxins produced by a wide range of organisms.  These pore forming 
toxins can be crucial for pathogenesis of various organisms requiring pore formation.  
Functional pore formation results in membrane disruption, a consequence which can be 
manipulated for a number of various functions including destruction of immune cells, 
translocation of bacterial effectors into a eukaryotic cell[117], as well as phagosomal 
escape[104, 140].  Interestingly, these toxins which are produced by organisms with an 
intracellular component of their lifestyle display optimal/enhanced activity at acidic pHs 
consistent with their use in the acidic phagosome.  The listerial derived CDCs (including LLO) are 
particularly well suited to their role as an escape mechanism from the phagosome, displaying 
significant activity at acidic pHs and rapidly losing activity at neutral pH.  This elaborate and 
specific mechanism ensures that once the toxin mediates escape from the phagosome, it will 
maintain the integrity of the cell allowing intracellular replication of the bacteria.  The 
molecular basis for this pH dependent activity has been localized to three residues in domain 4 
of the protein, which act as a sensor for increased pH and trigger premature unfolding of the 
transmembrane regions and subsequent inactivation of the protein[103].  For a time, it was 
thought that pH dependent activity was specific only to Listeria derived toxins and that all other 
toxins were “pH insensitive”[141].  While such drastic pH dependence has only been shown for 
LLO, further studies demonstrated that PFO also displays a pH optimum, with greatly enhanced 
activity at pH 5.5-6 (although still able to function at neutral pH, unlike the Listeria derived 
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CDCs)[142].  Studies of PFO have suggested that at low pH, a partial unfolding event occurs, 
which primes the protein for membrane insertion.   
The data on PFO and LLO suggest that CDCs may have evolved mechanisms which make them 
well suited to their site of action, the acidified phagosome.  Given that L. iners can persist in a 
normal and BV states, where the pH can change from acidic to more neutral, we sought to 
understand how pH would affect the activity of its pore forming toxin, inerolysin[143].  Here, 
we demonstrate that INY shows a pH optimum, with significantly greater hemolytic activity at 
pH 4.5 than 7.4.  We also attempt to understand the molecular basis for this pH dependent 
activity.  Our work here suggests that pH dependent activity may be common to the family of 
CDCs, making certain toxins well suited to their respective physiological niches. 
3.2 Materials and Methods 
 
3.2.1 Cloning and expression of CDCs 
The listeriolysin O (LLO) ORF lacking its predicted signal sequence was amplified by PCR from L. 
monocytogenes BAA751 genomic DNA using primers BamHI-LLO-F 
(GCCGCCGGATCCAAGGATGCATCTGCATTC AATAAAG) and LLO-R-XhoI 
(GCCGCCCTCGAGTTATTCGATTGGATT ATCTAC). The ILY ORF lacking its predicted signal 
sequence was amplified from S. intermedius ATCC 27335 genomic DNA using primers BamHI-
ILY-F (GCCGCCGGATCCGCATTCGCTGAAA CACCTACC) and ILY-R-XhoI 
(GCCGCCCTCGAGTTAATCAGTGTTATC TTTCAC). Amplifications were performed using Phusion 
proofreading polymerase (New England BioLabs). A vector encoding a codon-optimized VLY 
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sequence (predicted amino acid sequence identical to that of the VLY from G. vaginalis ATCC 
14018 lacking the signal sequence, codon optimized for expression in E. coli) flanked by NdeI 
and XhoI restriction sites was purchased from GenScript.  For the creation of the INY double 
mutant, primers were used to replace the threonine at position 200 to an glutamate using 
primer pair primers NheI-INY-F (GCCGCCGCTAGCA ATACTGAGCCAAAAACAGCTATTG) and 
INY_Thr200_GluR(GCTTTGAGCACTTTCTGTATCATATTCAATTC)  and 
INY_Thr200_GluR(GAATTGAATATGATACAGAAAGTGCTCAAAGC) and XhoI-INY-R (GCCGCCCTCG 
AGTTAGTCATTTTTTACTTCTTCTTTG).  This was followed by replacement of a serine residue at 
position 239 with to a glutamate using NheI-INY-F (GCCGCCGCTAGCA 
ATACTGAGCCAAAAACAGCTATTG) and INY_Ser239_GluR 
(CTTAAAGTTAACAATTTCTGCTTGTTTCTC ) and INY_Ser239_GluF 
(GAGAAACAAGCAGAAATTGTTAACTTTAAG) and XhoI-INY-R (GCCGCCCTCG 
AGTTAGTCATTTTTTACTTCTTCTTTG).   The INY mutant showing reduced oligomerization 
capability (L508D) was created by introduction of the point mutation  by PCR amplification from 
L. iners DSM13335 genomic DNA using primers NheI-
INYL508D0F(GCCGCCGCTAGCAATACTGAGCCAAAAACAGCTATTG) and INYL508D-R-
XhoI(GCCGCCCTCGAGTTAGTCATTTTTTACTTCTTCTTTGTGTTTAGGTCTATCAGTCGTACCC).  
Restriction sites are underlined and in bold.  Introduction of the leucine to aspartate mutation 
is underlined.  Protein purification was done as previously described in Chapter 2 
3.2.2 Erythrocyte lysis assay 
Preparation of erythrocytes was carried out as previously described in Chapter 2. To measure 
hemolysis, supernatant was removed, and the optical density at 415 nm (OD415) was 
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measured.  Hemolysis assays were carried out in the presence of buffer C (35 mM sodium 
phosphate, 125 mM sodium chloride) as previously described[103]. Toxins were preincubated 
at the indicated pH for 30 min before use in an endpoint assay.  In the indicated experiments, 
toxin was treated for 30 minutes at the indicated pH and then adjusted using HCl or NaOH and 
incubated for an additional 30 minutes at 4oC before use in an endpoint assay.   
3.2.3 Fluorescence spectroscopy 
Unfolding of LLO and INY was measured over time by monitoring the change in 1-
anilinonaphthalene-8-sulfonic acid (ANS; Molecular Probes) fluorescence [103]. Purified LLO or 
INY was diluted to a final concentration of 1M in 2 ml of buffer C (35 mM sodium phosphate, 
125 mM sodium chloride) in a quartz cuvette. Fluorescence was monitored continuously for 30 
min in a spectrophotometer with excitation and emission wavelengths set to 371 nm and 483 
nm, respectively. 
3.2.4 Binding activity of recombinant CDCs 
Recombinant CDCs (5µg/mL) were incubated for 30 min at 37oC at the either pH 4.5 or pH 7.4.  
400µl toxin was mixed with 400µl of 1% hRBCs on ice for 5 min or with a 1% solution of VK2 
cells for 20 min at 4oC in Buffer C (35 mM sodium phosphate, 125 mM sodium chloride) at the 
indicated pH.  Cells were recovered by centrifugation (9000rpm for 10 min at 4oC).  Cells were 
washed twice with ice cold PBS, and resuspended in 2X SDS buffer + 1% TX-100.  Bound CDC 




3.2.5 Binding of recombinant CDCs to immobilized cholesterol 
To assess the binding of CDCs to cholesterol, a PVDF binding assay was carried out.  Briefly, 20 
mg/mL cholesterol (dissolved in 1:1 chloroform:ethanol) was diluted to 20 μg/mL (dissolved in 
1:5 chloroform:ethanol), and 100 μl was added to each well (2 μg per well) of a 96 well plate 
with Immobiolon-P membrane (Millipore) at the bottom and allowed to dry overnight.  The 
cholesterol-coated wells were treated with blocking buffer consisting of 4% heat-inactivated 
fetal bovine serum in PBS for 1h.  CDCs at 2 µg/mL were treated for 30 min at either 37oC or 4oC 
at in Buffer C (35 mM sodium phosphate, 125 mM sodium chloride) at pH 4.5 or pH 7.4.  Toxin 
was diluted to 2nM in Buffer C with 4% heat inactivated fetal bovine serum and 100 µl was 
added to each well.  After 2 hours, wells were washed four times with blocking buffer, and 
treated with anti His-tag antibody (1:2000) for 1 hour.  Wells were washed four times with 
blocking buffer and antibody was detected with horseradish peroxidase-conjugated anti-mouse 
IgG (Santa Cruz) at a dilution of 1:2000.  The binding of CDCs to cholesterol was determined 
quantitatively by the addition of 100 μl of 3,3β,5,5β-tetramethylbenzidine (TMB).  The reaction 
was stopped by the addition of 50 µl of 2N H2SO4 and absorbance was measured at 450nm.  For 
INY and LLO, percent binding is measured relative to toxin treated at pH 4.5 and 4oC.  For PLY, 
percent binding is measure relative to toxin treated at pH 7.4 and 4oC. 
3.2.6 Protein degradation Assay 
Protein degradation was assessed by western blot analysis.  Briefly, CDCs (5 µg/mL) were 
treated for 37oC in buffer C (35 mM sodium phosphate, 125 mM sodium chloride) at pH 4.5 or 
7.4 for 30 min.  Protein levels were detected by western blot analysis using anti-his-tag 
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antibody.  Primary antibody was detected using horseradish peroxidase-conjugated anti-mouse 
IgG (Santa Cruz) at a dilution of 1:1000 and detected by enhanced chemiluminesence.   
3.2.7 SDS agarose gel electrophoresis separation of CDC monomer and oligomer 
SDS-AGE was carried out as described[144].  Briefly, 60 μg/mL of toxin was mixed with 1% 
hRBCs, in a final volume of 40 μl and incubated at 37oC for 30 min.  After 30min, glutaraldehyde 
was added to a final concentration of 5mM and incubated for an additional 2 min at room 
temperature.  Samples were solubilized SDS sample buffer and the complexes were analyzed on 
a 1.5% SDS-agarose gel (100 V, 120 min) and then transferred to nitrocellulose membranes. 
Protein bands were identified using mouse anti-his-tag antibody (Sigma) followed by 
horseradish peroxidase tagged goat anti-mouse secondary IgG. The bands were visualized using 


































































Table 3.2 Primers used for PLY domain swaps 
 
Table 3.2 Primers used for PLY domain swaps 
 
3.2.8 Transmission Electron Microscopy 
Erythrocyte ghost membranes were made by placing 10 μl of a 50% hRBC cell suspension in a 
drop of water and incubated at room temperature for 10 minutes to allow the membranes to 
rise to the air-liquid interface.  Formvar coated 300 mesh grids (Electron Microscopy Sciences) 
were placed onto the drop and incubated for 5 min.  INY (125 µg/mL) was pretreated in Buffer 
Domain Fusion Name Sequence














































C at pH 4.5 or pH 7.4 for 30 min and then a drop was placed onto the grid and incubated at 
37oC for 30 min.  Grids were stained with 2% phosphotungstic acid for 30 sec.  Samples were 
examined using a JEOL JEM-1200 EXII electron microscope.  Pictures were taken on an ORCA-HR 
digital camera (Hamamatsu) and recorded with the AMT Image Capture Engine.   
 
3.2.9 Construction of INY derivatives and chemical modification of cysteine residues with IANBD 
Proteins were purified as indicated previously.  Toxins were treated with 2.5mM DTT for 10  
minutes at room temperature and then dialyzed overnight to remove DTT.  Toxin derivatives  
were labeled with a 20-fold molar excess of the IANBD[iodoacetamido-N,N’-dimethyl-N-(7  
nitrobenz-2-oxa-1,3-diazolyl)ethylene-diamine; Molecular Probes] overnight at 4oC.  Following  
modification with the probe, excess was quenched with 1mM DTT for 10 minutes and probe  
was removed via extensive dialysis.  NBD measurements were carried out with an Infinite 200  
microplate reader (Tecan) using the following settings: an excitation wavelength of 480nm and  
an emission wavelength of 540 nm with a bandpass of 5nm.  Emission intensity was scanned  
between 500 and 600 nm at a resolution of 1 nm with an integration time of 1 sec.  10 µg of 
toxin was incubated with varying amounts of cholesterol in Buffer C for 30 minutes at 37oC.  
The fluorescence intensity of the unlabeled samples was subtracted from that of the 
fluorescent probe-labeled samples in order to control for the intrinsic fluorescence of the 
sample in the absence of probe.   
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Table 3.3 Primers used for construction of cysteine mutantsTable 3.3 Primers used for construc 
  
3.2.10 Statistical methods 
Hemolysis assay results are expressed as average values from three readings from one 
representative experiment.  Each experiment was repeated three times.  Data were analyzed by 
Student t test.  A P value of <0.05 was considered significant.   
 
3.3 Results 
3.3.1 Recombinant INY shows pH dependent activity which is distinct from LLO 
The CDCs have various pH-dependent activity profiles. ILY has activity across a wide pH 
range[128], while LLO (produced by L. monocytogenes) has an acidic pH optimum, consistent 
with its function within a vacuole during the Listeria life cycle[103]. The hemolytic activity of INY 
was measured as a function of pH and compared to the hemolytic activities of several other 
CDCs (Fig. 1A). ILYand VLY were both active at neutral pH and demonstrated a significant 
Toxin Primers Sequence
INY-CysAla-F
GA ATG TTA AGA TTC AAG AAG CTA CAG 
GCT TGG CAT G
INY-CysAla-R
CAT GCC AAG CCT GTA GCT TCT TGA ATC 
TTA ACA TTC A
INY-AspCys-F
GGA AAC AAC AAG CAA GAG TTG CAA 
AGT TCA AGC AGC TTT TG
INY-AspCys-R
CAA AAG CTG CTT GAA CTT TGC AAC TCT 
TGC TTG TTG TTT CC
INY-IleCys-F
ACT AGT GTT GTA GCT GTT TGC TTA GGT 
GGT AAC TC
INY-IleCys-R







decrease in activity at pH 4.5. This reduction in ILY activity at acidic pH was consistent with a 
previous report[128]. In contrast, INY demonstrated greater activity at a more acidic pH (4.5 to 
6.0), with decreased function at pH 7.4 (Fig 3.1A). The molecular basis of pH dependence has 
been extensively investigated for LLO[103]. To gain further insights into the pH-dependent 
activity of INY, we compared the activity of INY to that of LLO as a function of both pH and 
temperature. It has been previously shown that LLO responds to a pH increase by rapid 
unfolding and loss of activity. Maximal unfolding of LLO requires increases in both temperature 
and pH. With an increased pH, INY rapidly lost activity at both 23°C and 37°C (Fig 3.1B). This is in 
contrast to LLO, which showed a slight decrease with an increase in either pH or temperature 
and a more pronounced decrease in activity upon incubation at increased pH and increased 
temperature. Toxin unfolding in response to pH, as has been demonstrated for LLO, was 
measured using the fluorescent probe ANS, which binds hydrophobic sites on proteins. Addition 
of LLO to a solution of ANS led to an increase in fluorescence (Fig 3.1C) that was considerably 
more pronounced at pH 7.4. In contrast, INY demonstrated only a slight increase in 
fluorescence over time at pH 7.4, as well as pH 5.5 (Fig 3.1D).   To further distinguish the 
mechanism of pH dependent activity of INY, toxins were incubated at either pH 4.5 or pH 7.4 
for 30 minutes.  The pH was then shifted back to pH 4.5 followed by an additional 30 minute 
incubation.  Once LLO was inactivated by elevated pH, shifting the pH could not restore 
hemolytic activity.  Interestingly, the loss of activity seen with INY was reversible, and upon 
shifting the pH we see a restoration of hemolytic activity to levels comparable to that of pH 4.5 
treated toxin.  For LLO, a triad of acidic residues in domain 4 is responsible for sensing increased 
pH and driving unfolding of the protein.  In order to determine if the analogous residues in INY 
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were responsible for this unique pH dependent activity, they were mutated in order to 
resemble LLO.  In LLO three residues comprise this “acidic sensor”: Glu-208, Glu-247, and Asp 
320.  Fig 3.1F is a protein sequence alignment, highlighting the analogous residues in INY: Thr-
201, Ser-239, and Asp-312.  Inserting the triad of acidic sensor residues into INY was not 
sufficient to confer LLO-like activity on the protein and this recombinant mutant toxin 
















Figure 3.1 Recombinant INY shows pH dependent act
ivity distinct from that of LLO 
 
3.3.2 Membrane Binding activity of pH treated CDCs 
We examined the membrane binding activity of toxins at the indicated pH to determine if this 
first step was impaired at more basic pH.  There was no loss of membrane binding activity to 
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either hRBCs (Fig 3.2A) or VK2 epithelial cells (Fig 3.2B) under basic conditions for INY.  This is in 
contrast to LLO, which shows a significant loss of membrane binding activity.  The cholesterol 
dependent cytolysin (CDC) family is characterized by a dependence on cholesterol for hemolytic 
activity.  For most (with the exception of the human specific CDCs ILY and VLY), membrane 
cholesterol serves as the receptor to which they initially bind[145].  We determined whether 
cholesterol binding activity was intact after incubation under basic conditions.  INY and LLO 
were treated at pH 4.5 or pH 7.4 for 30 min at 37oC.  The amount of CDCs bound was then 
measured by ELISA using an anti-his-tag antibody.  After treatment of INY at pH 7.4, its binding 
was comparable to binding of toxin treated at pH 4.5 (Fig 3.2C).  Again, this is contrast to LLO, 
where treatment at pH 7.4 resulted in a significant reduction in cholesterol binding ability as 
compared to binding at pH 4.5.  Protein levels were assessed by western blot to ensure that the 
unique pH dependent activity was not due to protein degradation.  We observed comparable 











Figure 3.2 Membrane binding activity is intact and loss of activity is not due to protein degradation 
3.3.3  Several CDCs show pH dependent activity 
To date, pH dependent activity has only been described for the Listeria derived toxins[141]  as 
well as PFO[142].  Given that PLY is the most closely related non-species specific CDC, we 
examined the pH dependent activity of this toxin.  The hemolytic activity of PLY at pH 4.5 and 
pH 7.4 was measured across a range of concentrations and compared to INY.  The pH 
dependent profile of PLY is reversed as compared to INY, showing a loss of hemolytic activity at 
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pH 4.5 as compared to pH 7.4 (Fig 3.3A).  With the finding that both INY and PLY demonstrate 
pH dependent activity, we expanded the panel of CDCs tested to include arcanolysin (ALN) and 
pyolysin (PLO), produced by Arcanobacterium haemolyticum[146] and Arcanobacterium 
pyogenes[126] respectively.  Phylogenetically  divergent from INY, these toxins also 
demonstrated pH dependent activity.  ALN showed enhanced activity at pH 7.4 while PLO had 
enhanced activity at pH 4.5 (Fig 3.3 B).  PLY was either preincubated for 30min at 37oC at pH 4.5 
or pH 7.4.  The pH of the sample was then adjusted to pH 7.4 and incubated for an additional 30 
min at 4oC.  Similar to INY, PLY showed a loss of hemolytic activity (at pH 4.5), which was 
restored after the pH shift.  Like INY, this loss of hemolytic activity was not due to protein 
degradation (Fig 3.3E) at pH 4.5.  Binding of PLY to erythrocytes (Fig 3.3C) and cholesterol (Fig 




Figure 3.3 Several CDCs show pH dependent activity 
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3.3.4 Oligomerization properties of pH treated toxin 
After membrane binding, several structural changes occur which results in oligomerization of 
monomers into a prepore structure.  These large oligomeric complexes, ready for pore 
formation, are notably SDS resistant[147].  Briefly, toxin (preincubated at the indicated pH at 
37oC for 30 min) was incubated with red blood cells (2 x 108 cells/mL) for 30 min.  Samples were 
then solubilized with SDS without heating and separated by SDS-agarose gel electrophoresis, 
which should separate monomeric and oligomeric forms.  After 20 minutes, SDS resistant 
oligomers were detected at both pH treatments.  However, at pH 7.4 we detected a greater 
number of oligomers as compared to toxin treated at pH 4.5 (Fig 3.4A).  At pH 7.4, despite a loss 
of hemolytic activity, oligomerization can still occur.  Interestingly, we also detected a higher 
molecular weight species present in the pH 7.4 treated toxin, which was not present in the pH 
4.5 treated toxin.  PLY demonstrated competence for oligomer formation at both pH 
treatments as well, similar to INY (Fig 3.4B).  To further assess competence for oligomerization, 
we monitored this process on the surface of erythrocyte ghosts by transmission electron 
microscopy (TEM).  For pH 4.5 treated toxin, we observed ring like structures on the surface of 
the erythrocyte ghosts.  Notably, we observed some structures which possessed dimensions 
consistent with what has been see for other CDCs, but the majority of these pore structures 
were approximately 300-400nm in diameter, which is about 10 times greater than the size of 
pores observed for other known CDCs[148].  The presence of two species of pores has been 
observed for PFO previously, and it is yet unclear if these species are competent for pore 
formation[92].  At pH 7.4, no observable pores could be detected on the surface of the 
erythrocyte ghosts (Fig. 3.4C), despite the observation of high molecular weight structures in 
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our SDS-PAGE analysis.  Additionally, we observed disorganized regions on the surface of the 
erythrocyte ghosts (Fig 3.4D) which is consistent with disorganized linearly bound toxin seen 
with oligomerization defective mutants of streptolysinO[149].  This pattern of dark staining is 
also consistent with monomeric bound toxin, as seen previously with PFO in solution[92].  As an 
additional assesment of competence for oligomerization, we also attempted to monitor 
structural transitions that mediate this process.  Upon membrane binding, the rotation of β5 
loop away from the β4 sheet contributes to the formation of an SDS resistant prepore, and this 
can be monitored spectroscopically using the environmentally sensitive probe conjugated to a 
cysteine residue substituted for ILE-339 in β4.  Initially buried under the β5 sheet and in a 
nonpolar environment, this residue becomes exposed to the polar environment and 
fluorescence is quenched.  At either pH, we observed a comparable reduction in fluorescence 
intensity, indicating the presence of these structural changes in both pH treated toxins.  Taken 
together, our results indicate that at either pH, despite a loss of hemolytic activity, monomeric 











Figure 3.4 CDCs show no defect in oligomerization after pH treatment 
3.3.5 CDCs show a defect in membrane insertion after pH treatment 
Having determined that at both acidic and neutral pH, membrane binding activity was intact and toxins 
are competent for oligomerization, we assessed the final step in pore formation, the conversion of a 
prepore to a pore and insertion of the transmembrane helices.  In order to monitor these structural 
changes, we conjugated the environmentally sensitive probe NBD to a cysteine residue substituted for 
Asp-305 in TMH2.  Upon incubation with cholesterol crystals, we found that at pH 4.5 there was a 
significant increase in fluorescence intensity (Fig. 3.5).  In contrast, at pH 7.4, toxin incubated with 
cholesterol crystals showed no increase in fluorescence intensity, indicating a lack of insertion of 
transmembrane helices at this elevated pH (Fig. 3.5).  We attempted to monitor several other steps in 
pore formation by substituting other residues with cysteine: His 232 (which monitors insertion of TMH1) 
and Gly 214 (which monitors disruption of the domain 2-domain 3 interface and unfurling of the 





































difficult to observe changes in fluorescence intensity.  For His232, our labeling procedure seemed to be 
ineffective.     
Table 3.4 INY and its derivatives 
 







Figure 3.5 CDCs show a defect in membrane insertion after pH treatmentthis  
3.3.6  Localization of the pH dependent activity 
The crystal structures of several proteins (including PFO, ILY, and ALO)[150-152] have been 
solved.  These proteins have been shown to fold into similar three-dimensional structures, and 
it is highly likely that the other members of this family also fold into the same four domain 
structure.  Figure 3.6A shows the discontinuous nature of these domains in the primary 
structure of the protein.  In order to localize the pH dependent activity of the protein, chimeric 
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toxins were created which contained a single domain of INY (or a fragment of a domain) in 
place of the analogous residues in PLY.  These toxins were incubated at the indicated pH for 
30min at 37oC before being used in an erythrocyte lysis assay.  The chimeric toxin PLY-INYD4 
shows a pH dependent activity profile similar to PLY, showing a loss of activity at pH 4.5 (Fig 
3.6B).  The chimeric toxin PLY-INYD2 also displayed activity consistent with native PLY activity, 
showing greater hemolytic activity at pH 4.5 than at pH 7.4 (Fig 3.6C).  The pH dependent 
activity of the domain 3 chimeric toxins could not be fully assessed.  In a hemolysis assay, these 
constructs resulted in an “aggregation” phenotype, characterized by red blood cells sticking to 
the sides of the well plate rather than forming a defined pellet (data not shown).  Interestingly, 
when we examined these red blood cells, we found them to be intact rather than lysed red 
blood cells.  At higher concentrations (Appendix C Fig.C1), this construct was able to lyse red 
blood cells, but only at pH 4.5 (and not pH 7.4 where the aggregation phenotype was still 
observed).  In order to avoid the aggregation phenotype and assess the role of domain 3 in the 
pH dependent activity, we created two different chimeric toxins each containing one 
continuous fragment of domain 3.  The INYD3F1 construct contained amino acids 196-245 or 
domain 3 in a PLY background whereas INYD3F2 contained amino acids 292-366 in a PLY 
background.  Both of these toxins also demonstrated the aggregation phenotype seen for the 
full length domain 3 chimera (data not shown).  These constructs both behaved similarly to the 
full length domain 3 chimeric toxin, showing hemolytic activity at high concentrations 
(approximately 1000 fold greater than those needed for native INY) at pH 4.5 but not at pH 7.4 
(Appendix C Fig.C2).  In our assays, we have observed higher levels of background hemolysis for 
RBCs incubated at pH 4.5 than for RBCs incubated at pH 7.4 (data not shown).  Given the result 
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obtained with the chimeric toxins containing INY domain 3 in a PLY background, we attempted 
to create chimeric toxins with PLY domain 3 fragments in an INY background.  We were unable 
to clone PLY residues 148-197 in an INY background (PLYD3F1).  A chimeric toxin composed of 
PLY residues 244-318 in an INY background (PLY D3F2) showed activity consistent with native 
PLY losing activity at pH 4.5 (Fig 3.6D).  We next assessed the role of domain 1 in the pH 
dependent activity of the toxin. The chimeric toxin composed of INY residues 1-68 in a PLY 
background (INYD1F1) displayed the same aggregation phenotype as had been seen with the 
INY domain 3 chimeric toxins and showed hemolytic activity at pH 4.5, but only at 
concentrations approximately 1000 fold greater than those needed to achieve the same level of 
lysis as native INY (Appendix C Fig. 1B).  INYD1F2 and INYD1F3 behaved similarly to PLY, 
showing hemolytic activity at pH 7.4 and losing approximately all hemolytic activity at pH 
7.4(Fig 3.6E).  We were unable to create a chimeric protein consisting of INY amino acid 
residues 367-390 in a PLY background.  In order to address the role of this fragment (fragment 
4) of domain 1 in the pH dependent activity, we created a chimeric toxin of PLY amino acid 
residues 319-342 in an INY background.  This fusion protein behaved similarly to INY, showing 














Figure 3.6 Localization of the pH dependent activity 
3.4  Discussion 
pH dependent regulation of toxin activity has only been described in a few members of the CDC 
superfamily: The listerial derived cytolysins (including LLO) as well as PFO.  The evolution of this 
pH dependent activity is consistent with their use in the acidified phagosome to mediate escape 
into the cytosol.  L. iners has only been recently identified, and to date no work has been 
published that suggests that L. iners has an intracellular component to its lifestyle.  However, its 
normal physiological niche is the mucosal surface of the vaginal epithelium, which in a normal 
healthy vaginal tract is maintained at a low pH of about 4.   Although some have suggested that 
most of the CDCs, not including LLO and the listerial derived cytolysins, are pH insensitive[141], 
our work also suggests that pH dependent activity is a feature of a number of CDCs including 
pyolysin and inerolysin (which show an acidic pH optimum) as well as pneumolysin and 
arcanolysin (which show a basic pH optimum).  This is suggestive of a pan CDC regulatory 
mechanism, with various toxins having evolved to operate maximally within the pH range of 
their anatomical niches.   
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The molecular mechanisms of LLO pH dependent activity have been localized to a triad of 
charged residues in domain three which acts as a sensor for environmental pH.  Once it has 
mediated escape from the acidified phagosome, it experiences the more neutral pH of the 
cytosol, which then initiates a rapid and irreversible unfolding of the TMHs of the portion of the 
protein which inserts into the membrane, resulting in a complete loss of activity.  Interestingly, 
our results demonstrate the mechanism of pH dependent activity is distinct from that of LLO as 
it is reversible and affects the very last step of the pore forming mechanism, the insertion of the 
transmembrane domains, rather than the first step of pore formation, the binding and 
association with target membranes.  Interestingly, higher molecular weight structures were 
observed for toxin incubated at pH 7.4, supporting the idea that at this pH the toxin is stuck at 
the stage of oligomerization.  It is also possible that toxin treated at this pH forms two types of 
oligomeric structures, functional prepores as well as higher molecular weight structures which 
are non-functional.  As the concentration of toxin increases, a greater proportion of the 
oligomers are of this functional type, explaining the ability to overcome this loss of activity with 
greater amounts of toxin.  Our TEM analysis did not show any of these oligomeric strucutres, 
but our results indicated a different pattern of association with membranes at pH 7.4.  The 
functional significance of this unique association is not clear, but the SDS-AGE results as well as 
our spectroscopic analysis indicate competence for oligomerization.  The pore structures we 
observed at pH 4.5 were notably larger than any pore structure which has been identified 
previously.  Heterogeneity in pore size has been noted for other toxins[92], but pores this large 
have never been identified.  This result suggests that the pores produced by INY are larger than 
pores produced by other CDCs.  This discrepancy could be resolved through osmotic protection 
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experiments, getting a rough estimate of the pore size by using dextrans of different molecular 
sizes to block hemolytic activity of the pores.            
Our attempts to localize this pH dependent activity to particular residues were ultimately 
unsuccessful.  However, we know that the residues in domain 3 that confer pH dependent 
activity on LLO were not sufficient to confer this activity onto INY, confirming a distinct 
molecular mechanism for the pH dependent activity of INY.  The discovery that PLY, which is 
phylogenetically highly related to INY, displays a loss of activity at neutral pH presented the 
opportunity to localize the pH dependent activity of INY.  Our domain swap approach however 
was unable to confer PLY pH dependent activity onto INY (and the converse was also true, as 
we were unable to confer INY pH dependent activity onto PLY).  Some of these constructs were 
not functional in our assays and this is possibly due to incompatibility of INY domains in PLY (as 
making the converse swaps of PLY domains in an INY background yielded normal activity). 
pH dependent activity has been identified in pore forming toxins other than those belonging to 
CDC superfamily, including diphtheria toxin.  For diphtheria toxin, low pH is thought to 
neutralize acidic loops in the protein, facilitating their insertion into the membrane.  Data from 
PFO studies suggest that at low pH there is a partial unfolding event which primes the protein 
for membrane insertion[142].  Theoretical calculations of various crystal structures of PFO at 
neutral or acidic pH suggest that three residues, Asp58, Asp380, and Glu388, function to cause 
a premature breakage of the link between domain 2 and TMH1/2 of domain 3 at low pH[105].  
This explanation would be consistent with our results observed for the domain swaps, 
indicating the requirement of residues in several domains for this pH dependent activity. 
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These studies demonstrate that INY has evolved to operate within its particular physiological 
niche, the relatively acidic vaginal tract.  While the molecular basis of this activity has not yet 
been identified, functionally, INY in the presence of elevated pH shows a defect in the final step 
of pore formation, prepore to pore conversion.  Additionally, our results suggest that the whole 

















Chapter 4: L. iners induces unique signaling in the vaginal epithelium 
 
4.1 Introduction 
The vaginal epithelium represents the first barrier to pathogen invasion and provides more than 
just a physical barrier.  It possesses an innate immune system which can be selectively 
activated, allowing it to initiate appropriate responses to pathogenic and commensal species.  
Via the production of proinflammatory cytokines as well as antimicrobial peptides (defensins), 
the vaginal epithelium can initiate responses to deal with the vast number of organisms 
colonizing this surface.  The production of these immune system mediators is not only crucial to 
defense, but has been shown to affect, and perhaps shape, the composition of the colonizing 
micromicrobiota [153-155]. 
Although this microbiota is dynamic, complex, and poorly understood the dominant species 
present in a normal healthy vaginal tract are lactobacilli, with L. crispatus, L. gasserii, and L. 
jensenii being the most commonly isolated organisms.  Interestingly, the microbiota tends to be 
dominated by one or two Lactobacillus species rather than being a heterogenous mix of 
species[156].  Several studies have suggested that the presence of Lactobacillus species in the 
vaginal tract prevents the growth of potential pathogens[12].  A loss of these protective species 
and an overgrowth of these potential pathogens is characteristic of disease states, including 
bacterial vaginosis (BV).  This dysbiosis is associated with significant adverse consequences 
including an increased risk for preterm birth.  The link between preterm labor and BV is 
supported by epidemiological data but the exact mechanisms remain unclear.  Implicated in 
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this process are IL-8, IL-6, TNFα, as well as the production of prostaglandins and matrix 
metalloproteases[46], contributing to premature cervical ripening and uterine contractions.[46] 
L. iners is a recently identified member of the vaginal tract and epidemiological studies suggest 
that L. iners does not behave like traditionally protective lactobacilli, and rather than 
contributing to stability is actually associated with increased diversity[122] and transitions into 
a BV state[66].  We hypothesize that L. iners, despite being a Lactobacillus species, possesses 
pathogenic potential and could contribute to BV and BV associated preterm labor.  Here, we 
demonstrate that L. iners induces unique signaling in the vaginal tract.  Compared to L. 
crispatus (a protective species) and even G. vaginalis (a BV associated species), L. iners induced 
responses in the vaginal epithelium, creating an environment characterized by elevated 
proinflammatory mediators and rich in antimicrobial peptides.  We hypothesize that this may 
contribute to the altered vaginal microbiota seen in BV as well as BV associated preterm labor.       
4.2 Materials and Methods 
4.2.1 Epithelial Cell Lines 
The immortalized human vaginal epithelial cell line VK2/E6E7 was purchased from ATCC (CRL-
2616).  VK2 cells were cultured in Keratinocyte-SFM (Gibco-BRL) supplemented with 5 ng/mL 
recombinant epidermal growth factor, 50 µg/mL bovine pituitary extract, 400µM CaCl2,10 
µg/mL ciprofloxacin at 37°C in a humidified atmosphere with 5% CO2. 
4.2.2 Bacterial Cell Lines 
L. iners strains were grown on Columbia agar with 5% sheep blood.  L. iners type strain DSM 
13335, the genome of which has been sequenced, was obtained from the Deutsche Sammlung 
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von Mikroorganismen und Zellkulturen.  L. iners strain UPII 143-D(HM-126) and L. iners strain 
UPII 60-B(HM-131) were obtained  from BEI resources.  L. iners liquid cultures were grown in 
iners media (1% proteose peptone, 1% beef extract, .5% yeast extract, 85.6mM sodium 
chloride, .830 mM magnesium sulfate, .331mM manganese (II) sulfate, 11.48mM dipotassium 
phosphate, 2% glucose, 10% Fetal Bovine Serum).   L. crispatus strains were grown on MRS 
agar/MRS broth.  L. crispatus type strain ATCC33820 was obtained from ATCC.   
4.2.3 Cloning and expression of mutant CDCs 
For the construction of the pore formation deficient mutant, a tryptophan residue at position 




and INY-XhoI-R(GCCGCCCTCGAGTTAGTCATTTTTTACTTCTTCTTTG). Tryptophan to phenylalanine 
mutation is underlined and in bold.  Restriction sites are underlined.  Overlaps are underlined 
and italicized.   
 
4.2.4 Stimulation of cell lines 
VK2/E6E7 vaginal epithelial cells were grown to confluence in 12 well plates.  Bacteria were 
heat killed for 15 minutes at 70oC and checked for the absence of live organisms by plating an 
aliquot onto the appropriate medium.  Heat killed bacteria were diluted in keratinocyte-SFM 
and VK2 cells were treated at an MOI of 10.  The plate was spun 39.2 x g for 5 min and then 
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incubated for 2 hours (to assess the production of proinflammatory cytokines) or 18 hours (to 
assess for the production of antimicrobial peptides).  The amount of LDH released into the cell 
supernatant was assayed using Cytotoxicity Detection Kit Plus (Roche) as per the 
manufacturer’s instructions.  Percent cytotoxicity was determined using the following formula: 
[(Test LDH-bc)/(hc-bc)] x100 where bc (background control) is an estimate of LDH activity in the 
assay medium and hc (high control) corresponds to the maximum releasable LDH activity in all 
cells.   
4.2.5 Quantitative real-time PCR 
RNA was isolated from cells using an RNAqueous-4PCR (Ambion) according to the 
manufacturer’s instructions.  A total of 1 µg of RNA was reverse transcribed into cDNA by using 
the high-capacity cDNA reverse transcription kit (Applied Biosystems).  The quantitative real-
time PCR was carried out using power SYBR green master mix in a StepOne Plus thermal cycler 
(Applied Biosystems). The relative quantification (RQ) values were calculated using a 
comparative threshold cycle (ΔΔCT) proGram on StepOne software version 2.0. 
4.2.6 Statistical Methods 
All results are expressed as average values from duplicate readings from one representative 
experiment.  Each experiment was repeated two times.  Data were analyzed by Student t test.  






Table 4.1 Primers for proinflammatory cytokine responses 
 
Table 4.1 Primers for proinflammatory cytokine responses 
Table 4.2 Primers for antimicrobial responses 
 
Table 4.2 Primers for antimicrobial respon 
 
Name Sequence
Interleukin 8 F TTGGCAGCCTTCCTGATT TC
Interleukin 8 R TATGCACTGACATCTAAGTTCTTTAG
GAPDH F GGGCGCCTGGTCACCAGGGCTG
GAPDH R GGGGCCATCCACAGTCTTCTG
Interleukin 6 F AAGAGTAACATGTGTGAAAGC
Interleukin 6 R CTACTCTCAAATCTGTTCTGG
COX-2 F TGAGCATCTACGGTTTGCTG
COX-2 R TGCTTGTCTGGAACAACTGC
Tumor necrosis factor alpha F TCTCCTTCCTGATCGTGGC
Tumor necrosis factor alpha R GGTTCAGCCACTGGAGCT
Name Sequence
Human Beta Defensin-2 forward ATCAGCCATGAGGGTCTTGT
Human Beta Defensin-2 reverse GAGACCACAGGTGCCAATTT
Human Beta Defensin-3 forward AGCCTAGCAGCTATGAGGATC
Human Beta Defensin-3 reverse CTT CGG CAG CAT TTT CGG CCA
Human Beta Defensin-4 forward ATCAGCCATGAGGGTCTTGT
Human Beta Defensin-4 reverse GAGACCACAGGTGCCAATTT
Human alpha defensin 5 forward ATGAGGCTACAACCCAGAAGC




4.3.1 L. iners induces proinflammatory signaling in the vaginal epithelium 
Epidemiological data as well as genomic studies suggest that L. iners is unlike its closely related 
vaginal counterparts.  Many of these studies suggest that L. iners has some pathogenic 
potential, possibly contributing to alterations of the vaginal microbiota or being less protective 
against disturbances[65, 66].  Others have suggested that L. iners could play a role in 
maintenance or restoration of a healthy vaginal environment[62].  In order to gain further 
insight into the role of this organism in the vaginal tract and how the vaginal epithelium 
responds to it (as pathogen or commensal), we treated VK2 vaginal epithelial cells with several 
heat killed strains of L. iners, L. crispatus, and G. vaginalis.  We found that the L. iners strains 
tested (13335, 60B, 143D) were able to induce significant upregulation of IL-8 (ranging from a 2 
fold to 10 fold increase)(Fig 4.1A).  All strains tested were able to induce an approximately 6 
fold increase in IL-6 transcripts (Fig 4.1B), and induced upregulation of TNFα (ranging from an 6 
fold to 10 fold increase)(Fig 4.1C). L. crispatus induced no significant production of these targets 
above the media alone control.  Interestingly, we also found that G. vaginalis, a BV associated 
species, did not induce significant production of any of these targets. We also examined the 
ability of L. iners to induce to production of COX-2 (Fig 4.1D).  All L. iners strains tested were 
able to induce an approximately six fold increase in COX-2 transcripts.  In addition to assessing 
the level of mRNA transcripts, we also assessed protein levels of IL-8.  Here, we found that the 
one strain of L. iners we tested, 13335, induced the production of IL-8 protein in a dose 
dependent manner.  At an MOI of 10, L. iners 13335 induced the production of IL-8 (300 pg/mL) 
after stimulation of VK2 cells for 18 hours (Fig 4.2).  In contrast, L. crispatus at a similar MOI 
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induced no significant IL-8 production, in excess of what the untreated cells produced (50 
pg/mL).  Taken together, these results demonstrate that L. iners induces the production of 
proinflammatory cytokines by the vaginal epithelium, and this not generally shared among 


















Figure 4.1 Heat killed L. iners induces proinflammaory cytokine production by VK2 vaginal epithelial cells 





4.3.2 Antibody to CDCs abrogates this proinflammatory cytokine response 
We have previously shown that L. iners produces INY, a pore forming toxin which belongs to the 
family of cholesterol dependent cytolysins(Chapter 1 and [143]).  This gene is notably missing 
from the genome sequences of other lactobacilli, including L. crispatus.  We hypothesized that 
this pore forming toxin is the main driver for the differential response to these organisms seen 
previously.  Our attempts to develop genetic tools for the manipulation of L. iners with the 
purpose of creating an INY knockout were unsuccessful (Appendix A).  To address the role of 
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this toxin in the responses seen with heat killed bacteria, we utilized a polyclonal antibody 
raised to a related CDC Vaginolysin (VLY), to neutralize any INY present.  Briefly, heat killed 
bacteria were preincubated with anti-VLY rabbit polyclonal antibody or prebleed (control rabbit 
serum from before immunization with VLY) before being used to stimulate VK2 vaginal 
epithelial cells.  Heat killed bacteria incubated with prebleed still induced significant production 
of IL-8 (ranging from a 2 fold to a 30 fold increase in transcripts), IL-6 (ranging from a 2 fold to 
10 fold increase in mRNA), TNFα (ranging from a 2 fold to 20 fold increase in mRNA), as well as 
COX-2 (ranging from 5 fold to 30 fold increase) (Fig 4.3 A,B,C, and D respectively).  Pre-
incubation with anti-VLY antibody abrogated the production of these targets to levels 










Figure 4.3 Antibody to CDCs abrogate
 response 
4.3.3 Purified Recombinant INY is sufficient for the proinflammatory cytokine response 
To further assess the role of the toxin in these responses, we wanted to determine if purified 
recombinant toxin alone was sufficient to induce the production of these proinflammatory 
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cytokines.  VK2 vaginal epithelial cells were treated with purified recombinant toxin alone or a 
mixture of toxin and heat killed L. crispatus.  Recombinant INY was able to induce significant 
upregulation of IL-8, IL-6, TNFα, and COX2 in a dose dependent manner.  An approximately 100 
fold increase in IL-8(Fig 4.4A), 90 fold increase in IL6 (Fig 4.4B), 25 fold increase in TNFα (Fig 
4.4C), and 10 fold increase in COX-2 (Fig 4.4D) was observed after stimulation with purified 




Figure 4.4 Recombinant INY can stimulate proinflammatory cyokine production 
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4.3.4 Pore formation is required for proinflammatory cytokine production 
TLRs play an important role in recognizing microbial infections and initiating responses, usually 
resulting in the elaboration of several proinflammatory cytokines.  Previous work has 
demonstrated that CDCs can act as more than just cytolytic toxins, and can induce 
proinflammatory signaling via direct recognition by TLR4[157, 158], induction of osmotic 
stress[134], as well as allowing the introduction of bacterial products into the cytosol of the cell 
and sensing by intracellular pattern recognition receptors[109].  We wanted to determine if the 
responses we observed were due to direct recognition of toxin or pore formation.  To address 
this, a point mutant toxoid (W481F) was created which was 1000 fold less efficient than wild 
type toxin at forming pores (Fig 4.5A).  We found that this mutant, although still able to bind to 
the surface of red blood cells at comparable levels (Fig.  4.5B) was unable to induce any 












Figure 4.5 Pore formation is required for proinflammatory cytokine production 
4.3.5 Heat killed L. iners induces a unique defensin profile 
The vaginal epithelium must discriminate between pathogen and commensal, initiating unique 
responses to each.  In addition to the production of proinflammatory cytokines, vaginal 
epithelial cells may also produce an array of antimicrobial peptides, and in other anatomical 
sites it has been suggested that these substances play a critical role in regulating the 
composition of the microbial microbiota[159].  We examined the defensin profile induced by L. 
iners and L. crispatus and found that L. iners stimulation of VK2 cells resulted in a 2 fold to 3.5 
fold increase in  HBD4 (Fig. 4.6A).  In response to stimulation with L. iners strain 60B, we 
observed a 2.5 fold increase in HD5 and in response to L. iners 13335 stimulation we observed 
an approximately 20 fold increase in HD5 (Fig. 4.6B),  Both strains tested induced an 
approximately 4-5 fold increase in HBD2 (Fig. 4.6C).  L. iners was not able to stimulate HBD3 
production, but we did note a downregulation of HBD3 by L. crispatus, although this was not 
statistically significant.   When purified recombinant INY was used, we did not see comparable 
induction of defensins as with whole heat killed bacteria.  Our results demonstrate that L. iners 
has the ability to induce responses in the vaginal epithelium, creating a unique vaginal 
environment, as compared to L. crispatus, a traditionally protective species.  We hypothesize 
that this unique complement of defensins has important implications for the composition of the 




      
 




Figure 4.6 Heat killed L. iners induces unique defensin production by VK2 vaginal epithelial cells 
 
4.4 Discussion   
Traditionally, a healthy vaginal tract is defined by a microbiota which is dominated by 
Lactobacillus species.  As culture independent methods for the identification of bacterial 
species has become more commonplace, our understanding of the composition of a normal 
vaginal tract has become more complete.  The most commonly isolated Lactobacillus strains are 
L. crispatus, L. gasseri, and L. johnsonii and the use of these culture independent techniques 
have expanded the group of vaginal colonizing bacteria to include a new Lactobacillus species, 
L. iners.  Ravel et. al demonstrated the ubiquitous nature of this organism, with 30% of his study 
population being dominated by this organism.  Vaginal lactobacilli are thought to prevent the 
growth of urogenital pathogens via the elaboration of lactic acid, hydrogen peroxide and 
bacteriocins.  Interestingly, L. iners displays paradoxical behavior as it is associated with 
increased transitions into BV states as well as showing a vaginal environment characterized by 
increased diversity and more elevated pH as compared to an L. crispatus dominated 
microbiota[122].  The idea that this organism possesses pathogenic potential is further 
supported with the identification of the first putative virulence factor, inerolysin, a pore 
forming toxin belonging to the family of cholesterol dependent cytolysins[143].  We sought to 
understand what the vaginal environment would look like for an L. iners dominated microbiota, 
and how this differed from a microbiota dominated by a traditionally protective Lactobacillus 
species, L. crispatus.   
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The vaginal epithelium is the initial point of contact between a microorganism and the host.  
This epithelium must be able to respond to commensal and pathogen and initiate appropriate 
responses to each.  Commensals like L. crispatus and L. jensenii have been shown to be fairly 
innocuous, initiating no significant proinflammatory signaling in the vaginal epithelium, 
whereas pathogenic species upregulate these targets[160].  Furthermore, these commensals 
have been shown to actually downregulate proinflammatory signaling after TLR 
stimulation[161].  Interestingly, we found that L. iners rather than behaving like a commensal 
lactobacilli, actually induced responses more characteristic of a pathogenic species 
characterized by increased production of IL-8, IL-6 and TNFα.  Additionally, we also looked at 
the induction of cyclooxygenase-2 which is responsible for the production of prostaglandins and 
found that L. iners strains also upregulated this target as well.  Excessive proinflammatory 
cytokine production can be harmful to a pregnancy and contribute to preterm labor[162-165].  
While the roles of these cytokines in preterm labor have not been fully elucidated, previous 
work demonstrates that IL-8 can induce neutrophil influx into the cervix where these immune 
cells can the produce MMP-8 (neutrophil collagenase) which can contribute to cervical ripening.  
TNFα can also contribute to cervical ripening and preterm labor via the induction of MMP-8, 
MMP-9[166]. IL-6 has been used as a biomarker for the prediction of preterm labor, and it is 
suggested that this inflammatory mediator could induce the upregulation of oxytocin receptor 
expression in the myometrium[167], which could contribute to uterine contractions.  It is also 
known that prostaglandin production by COX-2 can result in increased calcium concentrations 
in the myometrium which could contribute to uterine contractions.  Most of these studies have 
examined cytokines and neutrophil influx in the cervix, uterus, and maternal and fetal 
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membranes.  However, it is very likely that inflammatory mediators produced by the vaginal 
epithelium could ascend to induce changes further along the vaginal tract.  
Our results suggest that the main driver for the differential response of vaginal lactobacilli (L. 
iners vs. L. crispatus) is INY.  After neutralization of INY by an antibody raised to a related CDC, 
the responses we observed were completely abrogated.    Epithelial cells can detect the 
presence of toxins either via its pore forming abilities in response to calcium fluxes[134] or as a 
result of introduction of bacterial cell components through the pore[109].  Our results suggest 
that the induction of these targets is accomplished through calcium fluxes, as we used purified 
recombinant protein to induce these responses, in the absence of any additional bacterial 
components.  It is possible that our preparations of purified recombinant protein contain some 
contaminants which could enter the cytosol via the pore to induce these proinflammatory 
responses.  Further work examining the requirement of NOD receptors could shed light on the 
importance of translocation of bacterial components for the initiation of these responses.  
Additionally, CDCs could induce these responses by direct recognition of toxin via TLR4[157].  
We show that pore formation, and not direct recognition is responsible for the responses we 
observed, as INY toxoid (INYW481F) was unable to induce these responses despite similar 
membrane binding activity.    
In addition to providing a physical barrier, the vaginal epithelium can antagonize the growth of 
potential pathogens via the production of defensins.  These antimicrobial peptides have the 
ability to directly inhibit the growth of microorganisms, as well as more complex effects linking 
the innate and adaptive immune system.  Additionally, it has been demonstrated that these 
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antimicrobial peptides can shape the composition of the microbiota[155, 168].   We 
demonstrate that L. iners induces the production of a unique profile of defensins, as compared 
to L. crispatus which did not induce any of the targets we assessed and actually seemed to 
downregulate them.  In a study of a pregnant population, vaginal fluid from women who had an 
intermediate microbiota (which is thought to be dominated by L. iners) was enriched in 
defensins, as compared to normal microbiota as well as women with frank bacterial 
vaginosis[169].  Interestingly, the production of INY by this strain is not what drives this 
response, and requires some unknown stimulating factor.  We suggest that a L. iners dominated 
microbiota, via the production of several antimicrobial targets can contribute to alterations and 
potentially dysbiosis of the vaginal micromicrobiota, resulting in a transition to a BV state and a 
reduction in the level of defensins.  More work is required to understand the full effect that 
production of these defensins have on health and disease in the vaginal tract. 
We present evidence that clearly demonstrates that L. iners and L. crispatus induce unique 
responses in the vaginal epithelium.  These data suggests that the vaginal environment of an L. 
iners dominated microbiota is distinct from that of an L. crispatus domainted microbiota, 
characterized by increased proinflammatory cytokine production and a unique profile of 
defensins.   This altered defensin profile potentially contributes to the dysbiosis seen in 
bacterial vaginosis, shaping the micromicrobiota in a way that is distinct from the way in which 
an L. crispatus dominated microbiota.  Attempts to treat bacterial vaginosis (a state not rich in 
proinflammatory mediators) and limit preterm labor have been unsuccessful, suggesting that 
the events contributing to preterm labor have set in long before we ever see an episode of BV.  
Given the ability of L. iners to persist in both “normal” and BV states, the chronic elevated  
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proinflammatory cytokine profile could potentially contribute to BV associated preterm labor.  
Figure 4.7 outlines the role L. iners may play in vaginal health.  The finding that INY is important 
in these responses presents a new target for limiting the incidence of preterm labor.  Further 
study is required to determine if these responses, in vivo, could result in alterations of the 







Figure 4.7 Proposed model for the role of L. iners in the vaginal tract 
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Chapter 5: Summary 
5.1 Summary of Results 
L. iners is a recently identified constituent of the vaginal tract.  Initially overlooked because of 
its fastidious nature, the use of cultivation independent techniques for identification allowed 
for the expansion of the repertoire of Lactobacillus species colonizing the vaginal tract to 
include this organism.  Traditionally, lactobacilli have been ascribed protective and stabilizing 
effects, contributing to the overall health of the vaginal tract[12, 13].  Techniques for the 
molecular identification of bacterial species have led to the understanding that the lactobacilli 
colonizing the vaginal tract are not a single species, but rather a group of distinct species 
including L. crispatus, L. gasseri, L. jensenii, and L. iners.  Epidemiological studies have furthered 
our knowledge about the role of these organisms in the vaginal tract, and have suggested that 
attributing a protective function to these species as a whole may not accurately reflect the role 
they play in shaping the vaginal microbiota and determining the health of the vaginal tract[9, 
121].  In particular, L. iners was found to be associated with increased transitions into BV states 
while L. crispatus was not, suggesting that L. iners has pathogenic potential.  It is this idea which 
led us to look for putative virulence factors in the genome of this organism.  Our results 
demonstrate that L. iners produces a pore forming toxin which belongs to the cholesterol 
dependent cytolysin (CDC) superfamily.  This family of toxins is secreted by a wide range of 
Gram positive and Gram negative organisms, and play important roles in the pathogenic 
mechanisms of the bacteria which secrete them.  The three dimensional structure of several 
CDCs have been solved, and across the family there is a high level of sequence identity and 
similarity, suggesting that this family of toxins possesses similar three-dimensional structure 
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and thus function in similar ways[105, 152, 170].  As their name suggests, these toxins are 
dependent on cholesterol to serve as the initial receptor mediating pore formation.  While 
these varied toxins all act through the same mechanism, pore formation, their activity may be 
required at particular times during the life cycle of the organism.  Regulation may occur at the 
level of transcription, translation, or post-translationally.  In our review of the literature, there 
has been only a single report of regulation at the level of transcription, demonstrating that the 
CDC produced by B. anthracis was regulated by external conditions[116].  Greater evidence for 
regulation at the level of activity has been shown for both LLO and PFO, showing optimal 
activity at acidic pH[102, 142].  The molecular basis for this activity has been identified in LLO, 
but not PFO[103].   Furthermore, no other groups have demonstrated pH dependent activity for 
any other members of this toxin family.  Given that this organism occupies a normally acidic 
nice, we hypothesized that this toxin (like LLO and PFO) would show an acidic pH optimum and 
that this activity was a common mechanism for regulation among many members of the class 
of cholesterol dependent cytolysin.    
Additionally, we sought to explain the paradoxical behavior of L. iners among lactobacilli, 
demonstrating increased transitions of the vaginal microbiota in women with a microbiota 
dominated by this species.  Our work here demonstrates that L. iners induces unique signaling 
in the vaginal epithelium which we hypothesize contributes to its paradoxical behavior.  These 






5.2 Identification and Characterization of the Cholesterol Dependent Cytolysin produced by L. 
iners 
L. iners  is an atypical organism which has been recently identified due to the use of culture 
independent methods for identification of microbial species.  Epidemiological studies suggest 
that this organism behaves more like a pathogen than a protective lactobacillus species, 
demonstrating reduced stability of the vaginal microbiota in individuals colonized by L. iners as 
compared to L. crispatus. This paradoxical behavior led us to look for toxins resembling 
vaginolysin (produced by G. vaginalis, a potential BV associated pathogen) in the genome of 
this organism.  BLAST analysis resulted in the identification of an ORF with a high similarity to 
vaginolysin in all of the sequenced L. iners strains available on NCBI.  Interestingly, the presence 
of this putative toxin was unique to L. iners strains and not present in any of the other vaginal 
lactobacillus species for which fully sequenced genomes were available.  This toxin was named 
Inerolysin (INY).  This is the first report of INY being purified, and we sought to characterize it.  
Recombinant INY displayed non-species restricted activity that displayed characteristics 
common to the family of cholesterol dependent cytolysin superfamily: activated by DTT and 
inhibited by the addition of exogenous cholesterol.  Additionally, antibody raised to a related 
family member was able to recognize, and neutralize INY.  Our results expand the family of 
cholesterol dependent cytolysins to include the pore forming toxin produced by L.  iners, 
referred to as INY.  The identification of this putative virulence factor began to lend support to 
the idea that L. iners possessed pathogenic potential and could contribute to disease in the 
vaginal tract.  The expansion of this family of toxins provides further opportunity to study the 
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structure-function relationship of the CDC superfamily as well as further our knowledge of the 
mechanism of pore formation.    
5.3 Characterization of the pH dependent activity of INY 
Others have demonstrated that CDCs produced by organisms with an intracellular component 
to their lifecycle, have evolved to be well suited to the acidic pH of the phagosome.  Although it 
has not been shown that L. iners has an intracellular lifestyle, it does normally occupy the 
acidified vaginal tract (pH 4.0) and so we sought to determine if INY demonstrated pH 
dependent regulation similar to PFO and LLO.  Our results demonstrated that the acidic pH 
optimum we see for INY is distinct from LLO, as it is reversible in INY, and LLO like activity could 
not be conferred onto INY by just the addition of the analogous “sensor” residues which are 
responsible for the pH dependence of LLO.  We determined that membrane binding, and 
oligomerization could proceed, but the final step in pore formation is defective at more neutral 
pH.  Interestingly, pH dependent activity was not restricted to INY, but was also identified in 
pyolysin and arcanolysin, phyologenetically distant relatives of INY.  While most of the toxins 
that have been examined and in work from other groups as well as our work examining INY and 
PYO show optimal activity at acidic pH, this is the first report of toxins which exhibit optimal 
activity at more neutral pH.  Interestingly, those toxins which demonstrate acidic pHs occupy an 
acidic niche during their lifestyle.  In the case of Listeria and Clostridia, an acidic pH optimum is 
required for activity in the acidified phagosome.  Those which demonstrate more neutral pH 
have not been shown to occupy any intracellular or acidified niches, and remain mainly 
extracellular where the pH is normally more neutral.  Taken together, past work and the studies 
carried out in this work suggests that pH dependent regulation of toxin activity is a mechanism 
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common to the entire family and that each toxin may be particularly well suited to its 
physiological niche.  Further work is required to confirm that all CDCs have pH dependent 
activity.  Analysis of pneumolysin suggests that the mechanism of PLY pH dependent activity is 
the same as it is for INY, as membrane binding and oligomerization were intact at neutral pH.  
We did not directly test for transmembrane helix insertion spectroscopically as we did with INY, 
but it could be done in the future to confirm that the defect is at this stage of pore formation.  
Our attempts to localize the pH dependent activity were ultimately unsuccessful, but suggest 
that the pH dependent activity is a function of several domains, rather than just a single one as 
it is with LLO.  INY is well suited to its physiological niche, colonizing the acidified vaginal tract.  
INY shows optimal activity at acidic pH and so may be able to initiate changes in the normal 
acidified vaginal tract.  G. vaginalis, another organism which makes a CDC, is a potential vaginal 
pathogen whose exact role in BV has not yet been elucidated.  While it is possible that this toxin 
may play a role in contributing to disease and adverse consequences associated with BV, the 
fact that VLY has optimal activity at neutral pH argues against its role in initiating changes in the 
normally acidified vaginal tract.  Additionally, G. vaginalis and its associated toxin are probably 
not associated with initiating changes in the vaginal microbiota as these organisms are rarely 
found in large numbers in the normally acidified vaginal tract.  We suggest that INY is 
particularly well suited to acting on the vaginal mucosa when it is in a “normal” state and is 
acidified.  Through some unknown mechanisms (investigated in Chapter 3), this toxin may act 
to alter the vaginal microbiota, contribute to transitions into BV states, as well as contribute to 
BV associated adverse outcomes.  Additionally, the work carried out in this study furthers our 
knowledge of the ways in which CDC activity can be regulated and suggests that the entire 
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family of CDCs may be regulated by pH.  Further studies must be carried out to determine the 
molecular basis of this pH dependent regulation.   
      
5.4 Characterization of the responses of the vaginal epithelium to L. iners 
Given the paradoxical behavior of this organism, and its potential contribution to mediating 
transitions into BV states, we wanted to look at the responses of the vaginal epithelium to this 
organism in comparison to a traditionally protective Lactobacillus species.  Our results 
demonstrate that L. iners behaves more like a pathogenic species, inducing the production of 
proinflammatory cytokines IL-8, IL-6, and TNFα.  Additionally, we hypothesized that this 
organism could be a major factor in the etiology of BV associated preterm labor, given its ability 
to persist in both normal and BV states.  We found that L. iners induced significant production 
of COX-2, which plays a large role in preterm labor (in addition to the proinflammatory 
cytokines mentioned previously).  The main driver for this response was found to be INY, and 
this response required active pore formation.  Further work is required to clearly demonstrate a 
link between L. iners and preterm birth, but if INY does contribute to this adverse consequence 
it presents a new target for limiting the incidence of BV associated preterm labor.  Our results 
also demonstrate that L. iners induces the production of a unique profile of defensins in the 
vaginal tract.  We speculate that this unique signaling could contribute to instability and 
increased frequency of transition into a BV state associated with L. iners colonization.  Further 
work is required to understand how this complement of defensins translates to actual changes 
in the composition of the microbial microbiota.  While we were unable to accomplish this, 
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mouse models of L. iners colonization could yield a significant amount of information with 
regards to the vaginal environment dominated by L. iners.   Given the non-species specific 
nature of this toxin, there is no reason to suspect that L. iners could not colonize the vaginal 
mucosa of the mouse.  However, one potential problem with this model is that the vaginal tract 
of the mouse is more basic than the human vagina[171], which could antagonize both the 
colonization by this organism as well as the activity of this toxin.  Additionally, purified toxin 
could be utilized in a mouse model to understand how this CDC may alter signaling in the 
vaginal mucosa.  Overall, the vaginal epithelium recognizes L. crispatus and L. iners in very 
different ways (mediated in part by INY) and induces very unique responses to each of them.  
This suggests that the presence of Lactobacillus species is not necessarily synonymous with 
vaginal health.  Current methods for diagnosis of BV depend on clinical criteria, such as Gram 
stain, whiff test, presence of discharge as well as clue cells.  These methods can detect the 
presence of BV in symptomatic women, but a significant number of women are asymptomatic.  
Better techniques are required to identify these asymptomatic women.  The work carried out 
here suggests that women who are preferentially colonized by L. iners may still be at risk for 
some of the adverse outcomes associated with BV, such as preterm labor.  This should prompt 
us to develop new tools to identify those women who are preferentially colonized by L. iners 
and thus at risk for BV and BV associated preterm labor.   
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Appendix A: Attempts to generate an INY knockout 
A1.1 Introduction 
Lactic acid bacteria are a group of organisms which are Gram-positive, non-spore forming bacteria, 
initially isolated from milk[172],  and can be found in fermented food and even the human body.  This 
group of organisms represents a major constituent of the gastrointestinal tract, where they function in 
host metabolism as well as protection against pathogen invasion/growth.  Given their crucial roles in the 
food industry as well as the human body as well as the fact that they are generally regarded as safe 
(GRAS), there has been significant interest in the genetic manipulation of these organisms.  Much of the 
interest has been in the realm of food development, being use for improved food preservation as well as 
flavoring[173].  One of the more medically relevant uses is for improved vaccine delivery.  These 
organisms provide attractive vehicles as they can be delivered orally (which can enhance adherence) 
and they can induce both mucosal and systemic immune responses.  As such, there is a significant 
amount of work that has been done on generating tools for genetic manipulation as well as techniques 
for transformation of these organisms.  
The development of lactobacillus plasmids and vectors has been ongoing for quite some time and great 
strides have been made in developing vectors which can be utilized for cloning.  Plasmids for use in 
these organisms can be broadly categorized as those which are promiscuous (and thus able to replicate 
in several organisms), those with two origins of replications (which facilitates manipulation in E. coli 
followed by transformation of lactobacilli), and native Lactobacillus plasmids engineered with a Gram 
negative origin of replication[174].  In our studies, we made use of several of these plasmids to optimize 
the conditions for the introduction of foreign DNA into this previously untransformed Lactobacillus 




In order to generate INY knockouts to study the role of this toxin in disease processes, we made use of 
integration vectors.  There has been a significant amount of work done to generate new integration 
vectors based on the presence of insertion sequences present normally in lactobacilli[175].  The 
efficiency of a number of these vectors has been improved by engineering plasmids with temperature 
sensitive origins of replication.  These plasmids should replicate at permissive temperatures, which 
should facilitate recovery of transformants even if our transformation efficiency is low.  These 
transformants can then be shifted to a higher non-permissive temperature which will facilitate 
integration.  We created several integration plasmids with a truncated form of INY to direct the 
integration events.   In the presence of antibiotic selection only those cells which have undergone the 
first crossover event and thus have integrated the plasmid should be resistant to that antibiotic.  These 
transformants would then be grown for a second time in the absence of selection to stimulate a second 
crossover event, resulting in a looping out of the original plasmid elements, and leaving either the full 
length gene or the truncated version of the gene in the genome.  In either case (either a single crossover 
event or a double crossover event), we would have a functional INY knockout.  However, the first 
situation could potentially have polar effects, affecting the expression of other genes upstream and 
downstream.  The second scenario would have created a knockout with no possibility of polar effects.  
Figure A1 shows a schematic of the proposed crossover events that would occur. 
The other major modifiable parameter we manipulated in order to generate a genetically modified 
organism was the mode by which DNA was introduced.  Electroporation has been widely used in 
lactobacilli, and acceptable transformation frequencies have been demonstrated for a number of 
lactobacillus species including L. gasseri and L. johnsonii[174, 176, 177]. Additionally, conjugation 
provides an alternative means for the introduction of foreign DNA into host cells.  This form of 
horizontal gene transfer has been demonstrated between lactobacillus species[178, 179] but also 
between Lactococcus and Lactobacillus [180].  In our study, we made use of the pAMβ1 plasmid which is 
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capable of self-transmission.  This plasmid has been used in the past to transmit genes encoding 
clumping factors to the host cell, and we hoped to utilize this same technique for the introduction of 
foreign DNA. This would be the first report of genetic manipulation of L. iners and would facilitate 
further work in understanding the role of this organism in health and disease of the vaginal tract.   
A1.2 Materials 
A1.2.1 Growth media and buffers 
Iners Media 
1% proteose peptone, 1% beef extract, .5% yeast extract, 85.6mM sodium chloride, .830 mM 
magnesium sulfate, .331mM manganese (II) sulfate, 11.48mM dipotassium phosphate, 2% glucose, 10% 
Fetal Bovine Serum 
Electroporation Buffer1 
0.4M sucrose, 1mM MgCl2, 5mM KH2PO4 pH 6.0 
Electroporation Buffer 2 
0.9M sucrose, 3mM MgCl2 
Electroporation Buffer 3 
0.5M sucrose, 10% glycerol 
Electroporation Buffer 4 










A1.2.2 Bacterial strains and plasmids 
Strains/Plasmid Relevant Characteristics Reference or source 
E. coli     
TOP10 
F mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 
deoR recA1 araD139 (ara-leu)7697 galU galK 
Invitrogen 
TG1 




NEB10+pRK21761; contains RK2 helper plasmid 
for conjugal transfer 
[181] 
      
L. iners     
13335 Type strain; isolated from human urine DSMZ 
60B isolated from human vagina ATCC 
143D isolated from human vagina ATCC 
      
Plasmids     
pCR2.1-TOPO Cloning vector; AmpR KmR   Invitrogen 
pARE252 
1.2kb INY fragment consisting of the first 507 
base pairs fused to the last 479 base pairs and 
lacking the internal 300bp 
This work 
pAM1 E. coli-Bifidobacteria shuttle vector; AmpR, ErmR [182] 
pARE253 
Truncated INY from pARE252 subcloned into 
XbaI/HindIII site of pAM1 
This work  
pEVP3 pneumococcal suicide vector; CmR [183] 
pARE254 
Truncated INY from pARE252 subcloned into 
KpnI/XbaI site of pEVP3 
This work  
pGID023 Integration vector; ErmR [184] 
pARE298 
Truncated INY from pARE252 subcloned into the 
BamHI/XbaI site of pGID023 
This work 
pJAK16 Cloning vector; CmR [185] 
pG+Host9 




Truncated INY from pARE252 subclones into the 
EcoRI site 
This work 
pRK21761 RK2 helper plasmid for transfer via conjugation  [156] 
pOri23 Expression vector for Gram positive; ErmR [187] 
pKS80 Expression vector for Gram positive; ErmR [188] 
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 for genetic manipulation 
A1.3 Procedures 
A1.3.1 Preparation of electrompetent cells 
L. iners was grown in iners media for approximately 26 hours (which corresponds to log phase) at 
37oC/5% CO2.  Iners media was also supplemented with sodium chloride (0.9M and 0.5M)[189] as well as 
glycine (0.8%, 1%, 2%, 2.5%).  No growth was observed in media supplemented with 0.9M NaCl and 
2.5% glycine.  These agents are known to destabilize the cell wall. Cells were harvested and in some 
cases pellets were treated with lysozyme or mutanolysin, in order to weaken the cell wall and facilitate 
the entry of foreign DNA into the bacterial cell.  Cell viability was tested after treatment by growth on 
plates with these cell wall weakening agents to ensure that they did not kill the bacterial cells. Cells were 
harvested by centrifugation, resuspended in half the original volume with electroporation buffer and 
incubated on ice for 10 minutes.  Cells were harvested by centrifugation and resuspended in 1/10 the 
volume with electroporation buffer and incubated on ice for 10 minutes.  Cells were harvested by 
centrifugation and resuspended in 1/100 the volume with electroporation buffer and incubated on ice 
for 10 minutes.  In some instances, cells were treated at 56oC for 5min, 10min, 20min or 30 min.  This 
was done to temporarily inactivate any host restriction systems that would cause degradation of 
introduced DNA[190, 191].  100μl aliquots were chilled on ice and used within an hour of preparation. 
A1.3.2 Electroporation 
  Plasmid DNA was isolated from E. coli by alkaline lysis method and varying amounts (0.1 ng, 1 ng, 10 
ng, 100ng, 1μg, 10μg) of DNA was added to the chilled cells in electroporation buffer.  Cells were 
incubated for 5 minutes with the DNA and then transferred into prechilled electroporation cuvettes 
(1mm gap or 2mm gap).  After incubation, varying pulses were delivered (1000V, 1500V, 2000V, 2500V), 
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25μF, 200Ώ.  Cells were immediately recovered in 1mL of iners media and grown at 37oC/5%CO2 for 2 
hours, 6 hours, or 8 hours.  
A1.3.3 Modification of plasmid DNA 
In some cases, in order to deal with the issue of host restriction modification systems instead of heat 
inactivating, we attempted an in vitro methylation procedure. Briefly, 500mL of L. iners strains 
(DSM1335, 60B, or 143D) were grown to an OD600 of approximately 1.0 and pelleted by centrifugation.  
These cells were washed with 100 mL of PENP buffer (10 mM potassium phosphate, 10 mM EDTA, 50 
mM NaCl and 0.2M PMSF, pH 7.0).  Cells were harvested by centrifugation and resuspended in a final 
volume of 10mL.  The cells were sonicated and debris was pelleted by centrifugation at 4oC.  The extract 
was saved on ice into 1 mL aliquots and 1 mL of glycerol was added as well as BSA (0.2 mg/mL) and 
stored at -20oC until use.  The DNA modification assay was carried out as follows: in a final volume of 
100 μl plasmid DNA (100 μg) was mixed with BSA (100 μg/mL), S-adenosylmethionine (80 µM), and TNE 
buffer [50 mM Tris (pH 7.5), 50 mM NaCl, 10 mM EDTA].  The reactions were incubated at 30oC for 16 
hours.  These methylated DNAs were then recovered by phenol chloroform extraction followed by 
ethanol precipitation.  Methylated DNA was stored at -20oC until use in the electroporation procedures 
mentioned above.   
 
A1.3.4 Conjugation 
L. iners strains (recipient) were grown either on Columbia blood agar plates or in iners media alone or 
supplemented with 0.5 M NaCl or 1% glycine for 2 days.  Cells were harvested, washed 3 times in iners 
media.  E. coli (donor) strains harboring the RK2 helper plasmid with integration vectors were grown in 
LB overnight and L. lactis (donor) harboring pAMβ1 was grown in GM17 overnight and washed in LB or 
GM17 respectively.  In some experiments, the recipient L. iners strain was treated with lysozyme or 
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mutanolysin for 30 min to weaken the cell wall and then washed 3 times in iners media to remove the 
lysozyme/mutanolysin.  After washes, cells were resuspended in 100 μl of the appropriate medium.  
Recipient (L. iners) was spotted onto the plate alone or in combination with the donor strains in varying 
amounts.  Plates were incubated at 37oC/5%CO2 for 1hr, 2hr, 4hr, 6hr, 8hr, or overnight.  Cell mixtures 
were then retrieved with a swab and plated onto selective media and grown for several days.  In some 
cases, in order to deal with the faster growth rate (and potential overgrowth) of the donor E. coli strains, 
aztreonam and nalidixic acid was included on the plates to prevent their growth and facilitate detection 
of putative transformants. 
 
A1.3.5 Natural Transformation 
After several attempts to introduce plasmid DNA with no success, we attempted to determine if L. iners 
strain DSM13335 could be transformed with genomic DNA.  Genomic DNA from the parent strain could 
possibly be a better transforming factor than plasmid DNA isolated from E. coli.  We made use of a 
spontaneous streptomycin resistant mutant of DSM13335.  Genomic DNA was isolated from this 
spontaneous streptomycin mutant using the DNeasy kit (Qiagen). 100mL cultures of L. iners were grown 
for approximately 36 hours (which corresponds to stationary phase), harvested by centrifugation and 
resuspendend in 1 mL of iners media.  Varying amounts of DNA (100 µg, 250 µg, and 500 µg) were 
added to the bacteria.  Cells were incubated with water as a negative control.  Cells were incubated at 
37oC for varying amounts of time (5min, 30min, 1hr, and 3hr).  After the allotted time period, cells were 
diluted and plated onto Columbia agar +5% sheep blood plates supplemented with streptomycin (40 
µg/mL).  No differences in the number of streptomycin resistant colony forming units between cells 





Ultimately, our attempts to genetically manipulate L. iners were unsuccessful.  Despite creating 
numerous vectors for the purpose of knocking out INY, a putative virulence factor for this organism, our 
results suggest that we were unable to introduce foreign DNA into our recipient L. iners strain.  
Impediments to transformation of Gram-positive organisms include the thick cell wall that can prevent 
entry of the DNA into the cell and host-restriction modification systems, which can degrade foreign DNA 
once it gains entry into the cytosol.  The genome of L iners possesses each of the components of the 
Type I restriction modification system.  We attempted to deal with these issues by treating the cells at 
56oC for varying amounts of time to temporarily inactivate host restriction-modification systems[192] 
before the addition of DNA and electroporation.   We also attempted to deal with the host restriction-
modification systems by treating plasmids derived from E. coli with cell free extracts from the recipient 
strains, in order to prevent degradation.  Additionally, we attempted transformation via conjugation 
with both a Gram negative (E. coli) and a Gram positive (L. lactis) donor.   Plasmids derived from E. coli 
could potentially be recognized as foreign and be degraded by host restriction modification systems of 
the organism.  We used genomic DNA in order to circumvent this issue, which would have the correct 
methylation pattern to evade the host restriction system.  Transformation of this genomic DNA into the 
recipient strain should yield more streptomycin resistant transformants than the negative control (as 
streptomycin resistance could arise as a result of a point mutation during growth).  All of our results 
suggest that L. iners strain DSM13335 is recalcitrant to transformation.  It is surprising that we were 
unable to transform this strain as related Lactobacillus strains, including L. crispatus and L gasseri [193, 
194] have been successfully transformed.  Additionally, an analysis of the genome suggests that this 
organism has the ability to be transformed as it possess all of the components of the natural 
transformation machinery, the com genes.  These genes encode pilus like proteins which serve to bind 
exogenous DNA, proteins which form channels in the membrane allowing the entry of the DNA, as well 
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as proteins involved in the creation of ssDNA[195-197].  The inability to transform L. iners could be strain 
specific, and it is worth attempting genetic manipulation with other strains of L. iners using the 
techniques outlined here.  Another potential option would be to identify /isolate native plasmids from L. 









Figure A Proposed crossover events for integration vectors 
Appendix B: Heterologous Expression of INY 
B.1 Introduction  
Our attempts to generate an INY knockout were unsuccessful.  In order to address the role of this toxin 
in contributing to proinflammatory cytokine signaling and defensin production, we sought to utilize a 
common system for the expression of this putative virulence factor.  For over three decades, tools have 
been developed for the heterologous expression of proteins in Lactococcus lactis.  This nonpathogenic, 
noncolonizing microorganism has been extensively used to understand the role of various factors from 
potentially pathogenic microorganisms in the etiology of disease.  This section will outline the attempts 
made to express inerolysin (INY) in this system, in the hopes of understanding the role of this virulence 
factor in health and disease of the vaginal tract. 
B.2 Materials and Methods 
B.2.1 Bacterial Strains and Cell lines 














Table B1.  Strains and Plasmids used 
Strains/Plasmid Relevant Characteristics Reference or source 
E. coli     
MC1061 
araD139, Δ(ara, leu)7697, ΔlacX74, galU-, galK-, hsr-, 
hsm+, strA Boca Scientific 
TOP10 
F mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 deoR 
recA1 araD139 (ara-leu)7697 galU galK Invitrogen 
TG1 K-12 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, (rK-mK-) Stratagene 
      
L. lactis     
MG1363 
Plasmid-free and prophage-cured derivative of NCDO 
712 [198] 
pNZ9000 pepN::nisRnisK; For nisin inducible expression  Boca Scientific 
      
Plasmids     
pKS80 
expression vector; constitutive from lactococcal 
promoter [188] 
pKS80-INY 
INY from DSM13335 cloned into BamHI site of pKS80 for 
constitutive expression This work 
pOri23 
expression vector;constitutive expression from p23 
lactococcal promoter Que (2001) 
pOri23-INY 
INY from DSM13335 cloned into BamHI/SalI sites of 
pOri23 for constitutive expression This work 
pTRKH3-
ermGFP 
expression vector; constitutive from erythromycin 
promoter Addgene 
pTRKH3-ermINY 
INY from DSM 13335 cloned downstream of erm 
promoter replacing GFP for constitutive expression This work 
pNZ8148 nisin inducible expression vector Boca Scientific 
pNZ8148-INY 
INY from DSM13335 cloned into KpnI/BamHI sites of 
pNZ8148 for nisin inducible expression This work 
  
 
Table B1 Plasmids and Strains used for heterologous expression 
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B.2.2 Cloning and expression of recombinant INY in L. lactis 
The open reading frame (ORF) encoding INY lacking the predicted signal sequence was cloned 
from L. iners DSM 13335 genomic DNA using primers BamHI-INY-F 
(GCCGCCGGATCCAATACTGAGCCAAAAACAGCTATTG) and SalI-INY-R 
(GCCGCCGTCGACTTAGTCATTTTTTACTTCTTCTTTG) for cloning into pOri23.  The ORF encoding 
INY was cloned from L. iners DSM13335 genomic DNA using primers SalI-INY-
F(GCCGCCGTCGATAATACTGAGCCAAAAACAGCTATTG) and BamHI-INY-
R(GCCGCCGGATCCTTAGTCATTTTTTACTTCTTCTTTG) for cloning into pTRKH3-ermGFP.  The ORF 
encoding INY lacking the predicted signal sequence was cloned from L. iners DSM 13335 
genomic DNA using primer BamHI-INY-F(GCCGCCGGATCCAATACTGAGCCAAAAACAGCTATTG) 
and BamHI-INY-R(GCCGCCGGATCCTTAGTCATTTTTTACTTCTTCTTTG) for cloning into the BclI site 
of pKS80.  Amplifications were performed using Phusion proofreading polymerase (New 
England Biolabs).  For cloning into pNZ8148, primers KpnI-INY-F 
(GCCGCCGGTACCAATACTGAGCCAAAAACAGCTATTG) and XbaI-INY-
R(GCCGCCTCTAGATTAGTCATTTTTTACTTCTTCTTTG) were used to clone INY.  The products of 
the PCR reaction were cloned via the indicated restriction sites into their respective vectors.  
For expression in pTRKH3-ermGFP, the GFP was removed by digestion with SalI and BamHI and 
replaced with INY.  Transformation of E. coli was carried out as per manufacturer instructions 
(Boca Scientific).  L. lactis transformations were carried out as per manufacturer instructions 




B.2.3 Nisin inducible expression of INY 
L. lactis harboring either pNZ8148-INY (ARLC12) or empty vector pNZ8148 (ARLC13) were 
grown overnight at 30oC in GM17 with 10µg/mL of chloramphenicol.  Overnight cultures were 
diluted 1/25 into 2x 400mL of fresh medium and grown until OD600 reached 0.4 (approximately 
4 hours).  Cultures were induced with 1 mg/mL of nisin (MP Biologicals) and induced for 2-3 
hours.  Cells were harvested by centrifugation and pellets were resuspended in PBS and 
incubated with lysozyme (10 mg/mL) and protease inhibitor for 30 minutes on ice.  Cells were 
sonicated to break them open, and lysate collected by centrifugation.  Protein concentrations 
were determined by modified Bradford assay.  Pellets were resuspended in LDS sample buffer 
(Invitrogen).  Recombinant INY was detected by western blot.  Samples were also used in an 
erythrocyte lysis assay.   
 
B.2.4 Detection of recombinant INY from L. lactis 
For detection of expression of INY from pKS80, pOri23, pTRKH-erm-INY, L. lactis was grown in 
GM17 overnight with 5 µg/mL erythromycin at 30oC.  400mL of overnight culture was harvested 
by centrifugation, resuspended in 40mL of PBS and treated with lysozyme (1 mg/mL) and 
protease inhibitor (sigma) for 30 minutes on ice.  Cells were sonicated on ice and cells were 
pelleted by centrifugation.  Protein concentrations were determined by a modified Bradford 
assay (Bio-Rad) and equal amounts of total protein were run on a 4 to 12% polyacrylamide gel 
(Invitrogen).  Proteins were transferred to polyvinylidene difluoride (PVDF) membrane, blocked 
with 5% milk and probed with anti-PLY monoclonal antibody (Santa Cruz Biotechnology. 1:1000 
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dilution).  The primary antibody was detected with horseradish peroxidase-conjugated mouse 
IgG by enhanced chemiluminesence.   
 
B.2.5 Erythrocyte Lysis Assay 
The use of human erythrocytes from healthy adult volunteers after verbal informed consent 
was obtained was approved by the Columbia University Institutional Review Board (protocol 
IRB-AAAC5641). Defibrinated sheep and horse blood was obtained from Fisher Scientific. 
Erythrocytes were washed in sterile PBS with 1 mM CaCl2 and 1 mM MgCl2. For endpoint 
assays, 100 µl of a 1% washed erythrocyte solution was mixed with 100 µl of lactococcus lysates 
or supernatant in a 96-well V bottom plate and incubated for 30 min at 37°C and 5% CO2. After 
30 min, the plates were spun at 2,000 rpm to pellet erythrocytes. Supernatant was removed, 





Interestingly, despite cloning the ORF encoding INY into pKS80 and pOri23, which should result 
in constitutive expression, we were unable to detect INY in lysates or pellets of these 
transformants.  Analysis of L. lactis strains harboring the plasmid pTRKH3-ermINY by western 
blot revealed the presence of an approximately 39kDa protein which cross-reacted with an anti-
PLY antibody (Figure B1).  Although cross reactive, this protein was not consistent with the 
predicted size of INY (57kDa). These lysates were found to have no lytic activity despite the 
addition of milligrams of total protein (data not shown).  In contrast, lysates from L. lactis 
harboring the pNZ8148-INY (ARLC12) contained an approximately 57kDa protein which was 
cross reactive with an anti-PLY antibody, consistent with the expression of INY from this strain.  
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This was unique to L. lactis harboring the construct, as cells harboring the empty vector 
(ARLC13) did not produce any protein recognized by the anti-PLY antibody (Figure B2).  In a 
functional erythrocyte lysis assay, we confirmed the presence of functional pore forming toxin 
in ARLC12 lysates as they were able to induce hemolysis of red blood cells (Figure B3).   
Conversely, ARLC13 lysates, which possessed no toxin were not able to induce lysis when 
comparable amounts of total protein were used.  We attempted to use these strains to induce 
production of proinflammatory cytokines from VK2 cells.  However, we were unable to detect 
any significant differences between strains (data not shown).  We hypothesize that intracellular 
components of the bacteria were able to induce production of proinflammatory cytokines, 
given we used lysates of the bacteria.  Thus these constructs proved to be less useful than 
expected in addressing the role of this toxin in these epithelial cell responses.   
 
B.4 Discussion  
Lactococcus lactis is commonly used as a tool for studying the role of putative virulence factors 
in disease pathogenesis.  Our goal was to express inerolysin in a related lactic acid bacteria 
(LAB) to understand the role of this toxin in proinflammatory cytokine production and to shed 
light on the role of this putative virulence factor in the pathogenesis of bacterial vaginosis (BV) 
and BV associated preterm labor.  We were unable to detect expression in strains harboring the 
constitutive expression vectors pKS80 and pOri23.  With the use of the constitutive expression 
vector using the erythromycin promoter, we obtained protein which cross reacted with 
antibody raised to a related CDC, pneumolysin.  This cross-reactive protein however was not 
the expected size of INY (approximately 57kDa).  When tested in a hemolysis assay, these 
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proteins were not able to induce any significant lysis, indicating production of a truncated 
protein.  We hypothesize that constitutive expression may put undue stress on the cell, 
providing pressure for recombination of the introduced plasmid, resulting in a truncated non-
functional protein.  Alternatively, constitutive expression may lead to intracellular accumulation 
of toxin, which may then be subject to degradation by intracellular proteases.  This is often a 
problem, which led to the development of inducible vectors for expression, allowing for growth 
to high density followed by shorter periods of induction to prevent excessive intracellular 
accumulation[199].  Using the nisin inducible expression vector pNZ8148 we were able to 
express full length, functional INY in this LAB.  However, when we used these constructs to 
stimulate vaginal epithelial cells to address the role of INY in initiating proinflammatory 
cytokine signaling, we found that our empty vector control also induced the same level of 
signaling.  It is not clear why this was the case, but it is possible that some soluble factor 
present in the cytosol of L. lactis has proinflammatory effects.  To address this possibility, we 
attempted to create INY fused to the usp45 secretion signal.  Usp45 is the major secreted 
protein from L. lactis and this strategy has been widely used to target proteins for secretion.  
Unfortunately, our attempts to create this construct were unsuccessful.  Overall, while we were 
able to achieve heterologous expression of the toxin in a related LAB, this strategy proved to be 











Figure C Additional figures for pH dependent activity 
 
 
